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Abstract
Vitamin D deficiency and Gestational Diabetes Mellitus (GDM) are common
health problems among pregnant women in the Middle East region including the
United Arab Emirates. However, a few prospective studies have investigated the
association between vitamin D deficiency and risk of GDM.
We estimated the incidence of GDM and examined the association of vitamin
D status in early pregnancy and the development of GDM in Emirati pregnant
women. In addition, we studied the association of diet, low physical activity and
other covariates with the risk of GDM.
We conducted a prospective cohort study on Emirati pregnant women who
visited eight primary healthcare clinics for antenatal care. A cohort of 563 women
was selected that included women aged 18 - 45 years, ≤ 15 weeks pregnant and were
free of GDM. The primary exposure was vitamin D deficiency (25(OH)D < 12
ng/ml) and vitamin D insufficiency (25(OH)D = 12 – 20 ng/l) as per Institute of
Medicine Criteria. Secondary exposure variables were levels of physical activity
(low, moderate and high as per WHO recommendations) and dietary intake. The
physical activity was measured by using Global Physical Activity Questionnaire
(GPAQ) and dietary intake was determined by using a validated Food Frequency
Questionnaire (FFQ). The outcome variable was GDM that was diagnosed by using
fasting and 75 g 2-hour postprandial Oral Glucose Tolerance Test (OGTT) in 24 - 28
weeks of gestation. The data on socio-demographic characteristics, personal and
family medical history, physical activity, dietary intake, blood pressure and
anthropometric indices were collected at baseline. In addition, fasting blood samples
were taken to measure fasting blood glucose and 25(OH)D levels. The participants
revisited antenatal clinics in their 24 - 28 weeks of gestation for the screening of
GDM. The status of GDM was confirmed by reviewing medical records of mothers
or by telephonic interview.
Overall, 58.3% of pregnant women had vitamin D deficiency and 26.4% had
insufficiency. The overall incidence of GDM was 15.2%. The incidence of GDM
was 16% in vitamin D deficient women, 16.1% in vitamin D insufficient women and
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10.7% in women with normal vitamin D. Adjusted logistic regression analysis
showed that vitamin D concentration (Adjusted Odds Ratio [AOR]: 0.99, 95%
Confidence Interval [CI]: 0.95 – 1.02, p = 0.450), vitamin D insufficiency (AOR:
2.11, 95% CI: 0.81 – 5.64, p = 0.101) and deficiency (AOR: 1.94, 95% CI: 0.88 –
5.32, p = 0.118) were not associated with GDM. Low (AOR: 1.09, 95% CI: 0.43 –
2.79, p = 0.850) and moderate (AOR: 0.78, 95% CI: 0.45 – 1.34, p = 0.372) physical
activity levels were not significantly associated with increased odds of GDM. The
Daily consumption of red meat (AOR: 6.16, 95% CI: 1.31 - 28.92, p = 0.021) and
dates (AOR: 1.86, 95% CI: 1.03 - 6.49, p = 0.043), family history of diabetes (AOR:
1.93, 95% CI: 1.02 - 3.62, p = 0.043) and Body Mass index (BMI) before pregnancy
(AOR: 1.07, 95% CI: 1.02 - 1.11, p = 0.003) were significantly associated with
GDM.
Vitamin D deficiency and physical activity were not associated with GDM,
while daily intake of red meat and dates, increasing BMI before pregnancy and
positive family history were positively associated with GDM. These findings are
congruent with some previous studies in the Middle East region and elsewhere and
provide guidelines to health stakeholders and healthcare providers for improving the
screening, prevention and management of GDM in Emirati women.
Keywords: Gestational Diabetes (GDM), Vitamin D deficiency, Vitamin D
insufficiency, Physical Activity, Diet, Obesity, Family History of Diabetes.
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)Title and Abstract (in Arabic

عالقة وقص فٍتامٍه د ،التغزٌة والىشاط الشٌاضً فً المشاحل األولى مه الحمل باإلصابة
بسكشي الحمل عىذ اإلماساتٍات

الملخص
ٝؼرثش سنش ٛاىذَو داىح ٍشظٞح ٍَٖح ،دٞس ذؼاّ ٍْٔ ٜاىنصٞش ٍِ اىْساء ف ٜدٗىح
اإلٍاساخ اىؼشتٞح اىَرذذج .ذشٞش اىذساساخ إى ٚأُ ّسثح اإلصاتح تسنش ٛاىذَو ف ٜدٗىح
اإلٍاساخ اىؼشتٞح اىَرذذج ذصو ٍا ت ،% 9;.@- %>.@ ِٞمَا ٝؼرثش سنش ٛاىذَو ػاٍو
خط٘سج تاىْسثح ىألً ٗاىجْ ِٞدٞس أّٔ ٝؤد ٛإىٍ ٚعاػفاخ ىنيَٖٞا ٗٝؼضص اإلصاتح تاىْ٘ع
اىصاّ ٍِ ٜاىسنش.ٛ
أشثرد تؼط اىذساساخ أُ ّقص فٞراٍ ِٞد ىٔ دٗس مثٞش ف ٜاإلصاتح تسنش ٛاىذَو ،مَا
أُ اىؼ٘اٍو اىَشذثطح تَْػ اىذٞاج ماىرغزٝح ٗاىشٝاظح ذيؼثاُ دٗسا ٍَٖا ف ٜػالض اىَشض
ٗاىسٞطشج ػي.ٔٞ
صََد ٕزٓ اىذساسح ىرشَو  <=:داٍو إٍاساذٞح فٍ ٜذْٝح سأط اىخَٞح ف ٜدٗىح
اإلٍاساخ اىؼشتٞح اىَرذذجٗ ،ىينشف ػِ ٗج٘د ػالقح تّ ِٞقص فٞراٍ ِٞد ٗذأشٞش ػ٘اٍو َّػ
اىذٞاج ماىرغزٝح ٗاىشٝاظح ،تاإلظافح إى ٚاىراسٝخ اىؼائي ٜىإلصاتح تاىسنشٍْٗ ٛسة مريح اىجسٌ
ٗػالقح ٕزٓ اىؼ٘اٍو تاإلصاتح تسنش ٛاىذَو.
ىٌ ّرَنِ ٍِ اىذص٘ه ػي ٚػالقح ٗاظذح ٗق٘ٝح تّ ِٞقص فٞراٍ ِٞد ٗاىْشاغ
اىشٝاظ ٜىيذ٘اٍو ٗاإلصاتح تسنش ٛاىذَو ،إال أّٔ ماّد ْٕاك ػالقح ق٘ٝح ت ِٞذْاٗه اىيذٌ
األدَش ،اىرَش ٍِ اىْادٞح اىغزائٞح ٗ اإلصاتح تسنش ٛاىذَو تاإلظافح إى ٚاىراسٝخ اىؼائيٜ
ىإلصاتح تاىسنشٍْٗ ٛسة مريح اىجسٌ اىيزاُ ماّا ٍِ اىؼ٘اٍو اىر ٜىٖا دٗس مثٞش ىإلصاتح
تسنش ٛاىذَو.

مفاهٍم البحث الشئٍسٍة :سنش ٛاىذَوّ ،قص فٞراٍ ِٞد  ،اىرغزٝح ،اىْشاغ اىشٝاظ،ٜ
اىراسٝخ اىؼائي ٜىإلصاتح تاىسنشٍْ ،ٛسة مريح اىجسٌ.
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Chapter 1: Introduction
1.1 Overview of Gestational Diabetes Mellitus

Gestational diabetes mellitus (GDM) is a type of diabetes that is developed
during pregnancy (ADA, 2015). During pregnancy, various hormones such as human
placental lactogen (HPL), estrogen, progesterone and cortisol are produced by the
placenta and ovaries to maintain the pregnancy, these hormones can disrupt the
uptake of insulin by body cells which could lead to insulin resistance and
consequently increase blood glucose concentrations (Reece et al., 2009). This
condition can develop at any gestational age; however, the majority of cases are
reported after 24 weeks (ADA, 2015).

1.2 Statement of the Problem

Recent data indicates that the burden of GDM has increased by 10 - 100% in
various populations during the last two decades (Ferrara et al., 2007; Dabelea et al.,
2005). This increase in the burden of GDM is thought to be somewhat responsible
for increasing burden of metabolic complications in both mothers and offspring
(Ferrara et al., 2007).

As mentioned earlier, vitamin D deficiency and GDM are common conditions
in Emirati pregnant women. However, a few studies have examined their association
in the region and country. In addition, these studies have various limitations. First,
the majority of previous studies used a cross-sectional study design; therefore,
temporality of the association between vitamin D and GDM could not be established.
Second, findings regarding the direction of association were inconsistent. Last, the
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most of studies did not account for confounding factors such as physical activity and
diet.

The UAE has experienced a rapid economic growth in recent decades, which
has considerably changed physical activity patterns and dietary habits of the people
(Ng et al., 2011). Since these life-style risk factors are strongly associated with GDM
and vitamin D deficiency, a limited research has explored the role of diet and
physical activity in the development of GDM in the region including the UAE.

It is well-established that exercise and dietary interventions can effectively
improve the management of type 2 diabetes and GDM (Asemi et al., 2013;
Brankston et al., 2004). However, in the UAE, primary focus is on the
pharmacological management of GDM, which needs to be shifted to lowering its risk
factors.

Prospective epidemiological studies are needed with better study designs and
quality to understand the pathophysiology and etiology of GDM and to determine the
association between vitamin D and other factors and GDM to decrease the burden
and impact of the condition on mothers and their children.

1.3 Relevant Literature

1.3.1 Pathophysiology and Etiology of Gestational Diabetes Mellitus

Insulin resistance is increased in pregnant women three times compared to
non-pregnant women. Auto-immune diabetes and β-cell dysfunction may correlated
with GDM and glucose intolerance during pregnancy as studies showed that the
prevalence of auto-immune markers of type 1 diabetes in women with GDM was
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between 0.98 and 14.7% (Baz et al., 2016). This is characterized by circulating
immune markers directed against pancreatic islets (anti-islet cell antibodies) or β-cell
antigens (such as Glutamic Acid Decarboxylase (GAD), or insulin autoantibodies
(Kaaja et al., 2008).

Studies showed that low insulin sensitivity and high insulin resistance during
pregnancy is related to pregnancy hormones such as estrogen, and progesterone
(influence β-cell function in early pregnancy and increase insulin resistance in late
pregnancy, cortisol (decreases glucose tolerance and increase blood glucose ), and
placental hormones as Human Placental Lactogen, and Prolactin increase during
pregnancy to preserve pregnancy (Baz et al., 2016)

It has been showed that Human Chorionic Gonadotropin (HCG) may have
no effect on insulin resistance during pregnancy as it increases during the first
trimester, the period which is associated with an increase in insulin sensitivity and
improvement of glucose tolerance (Palani et al., 2014). Prolactin may have no role
on glucose tolerance during pregnancy, as studies demonstrated that there were no
significant differences in the level of plasma prolactin among GDM and non-GDM
women. HPL has a main role in stimulating insulin-like growth factor (IGF)
production to provide more fuel for the fetus in form of glucose and amino acids (
Palani et al., 2014).

Studies demonstrated that adiponectin

levels (in adipose tissue which

controls local storage and distribution of fat by stimulating glucose uptake in
muscles), decrease with advancing gestation leading to high glucose levels ( Palani et
al., 2014).
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It has been shown that Tumor Necrosis Factor alpha (TNF-a) may promote
insulin resistance as it prohibit the insulin receptor, high level of TNF-a during
pregnancy associate with progressive insulin resistance (Baz et al., 2016).

1.3.2 Screening and Diagnosis of Gestational Diabetes Mellitus

The screening of GDM is usually based on Glucose Challenge Test (GCT),
while its diagnosis is based on Oral Glucose Tolerance Test (OGTT) (ADA, 2015).
In addition, two approaches are usually employed to screen and diagnose GDM. In
the two-step approach, 50g GCT is administered to screen women for GDM followed
by administering the 100g OGTT to GCT-positive women to diagnose GDM. The
one-step approach administers OGTT directly to diagnose GDM (ADA, 2015).

A substantial disagreement exists over the gestational age at which women
should be screened for GDM. In 1964, Sullivan and Mahan introduced the Oral
Glucose Tolerance Test (OGTT) to diagnose GDM. However, the gestational age
was not specified by them. In 1982, Carpenter and Coustan were the first to suggest
the gestational age of 24 - 33 weeks for screening of GDM. In 1996, the French
College of Gynecologists and Obstetricians (FCNGO) recommended using OGTT in
24 - 28 weeks of gestation in low-risk gestational women. In the same year, the
European Association for the Study of Diabetes (EASD) suggested a single step
OGTT at 28 weeks of gestation.

In 2000, the American Diabetes Association (ADA) recommended performing
the 75 g OGTT at 24 - 28 weeks of gestation. Since 2000, the majority of guidelines
have unanimously recommended to administer OGTT at 24 - 28 weeks of gestation
to screen for GDM; however, the rationale behind this approach has not been
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provided (Liu et al., 2016). Table 1.1 shows the history of OGTT for diagnosis of
GDM.

Table 1.1: History of Oral Glucose Tolerance Test for Diagnosis of GDM
Year

Author/Organization

Gestational Age

Major Contribution

1964

O‘ Sullivan & Mahan

No recommendation

To evaluate the risk of future
development of T2D in the mother
Introduced OGTT as a diagnostic
criterion for GDM

1967

NDDG

No recommendation

Test plasma rather than whole blood
to increase reproducibility

1982

Carpenter & Coustan

24 – 33 weeks

Apply the glucose oxidase method
rather than the Somogyi-Nelson
method to avoid the measurement of
other substances

1996

CNGOF

24 – 28 weeks

First to recommend gestational age
in low-risk pregnant women

1996

EASD

28 weeks

One step OGTT

2000

ADA

24 – 28 weeks

The cut-off to diagnose GDM was
set at 5.3-10.0-8.6 mmol/L in 75 g
OGTT

2008

HAPO study

24 – 32 weeks

Focused on perinatal outcomes
associated with OGTT value

2010

IADPSG

24 – 28 weeks

Adjusted diagnosis cut-offs

2011

ADA

24 – 28 weeks

2013

WHO

24 – 28 weeks

2015

ADA

24 – 28 weeks

ADA: American Diabetes Association, CNGOF: French College of Gynecologists &
Obstetricians, EASD: European Association for the Study of Diabetes, GDM: Gestational
Diabetes Mellitus, HAPO: Hyperglycemia & Adverse Pregnancy Outcomes, IADPSG:
International Association of Diabetes & Pregnancy Study Groups, NDBG: National Diabetes Data
Group, OGTT: Oral Glucose Tolerance Test, WHO: World Health Organization
Source: Adapted from (Liu et al., 2016)
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Table 1.2: Comparison of screening and diagnostic criteria of GDM
Advising
Body

Year

Screening
advise

NDDG
ADA

1979
2003

None
All but for
those at low
risk
None
All
All

C&C
IADPSG
CDA
CDA
SOGC

1982
2010
2003
2013
2002

BSD
NICE
EASD
JDS
DIPSI
ADIPS

2014
2015
1991
2013
2009
2014

NZSSD

1998

All except
low risk
All
Clinical risk
NS
All
All, unless
resources
limited
All

WHO

2013

All

Screening method
(Positive cut-off ≥)
50g GCT (7.8)
50g GCT (7.8)

75g OGTT
50g GCT (7.8)
50g GCT (7.8)
50g GCT (7.8)
FPG (4.7)
75g OGTT
NS
50g GCT (7.8)
75g OGTT

50g GCT (7.8)
75g (8.0)
75g OGTT

Glucose
load-g

Glucose Thresholds (mmol/L)
Fasting
1hr
2hr
3hr

No. of OGTT
values for
diagnosis

100
100
75

5.8
5.3
5.3

10.5
10.0
10.0

9.2
8.6
8.6

8.0
7.8
-

2
2
2

100
75
75
75
100
75
75
75
75
75
75
75

5.3
5.1
5.3
5.3
5.3
5.3
5.1
5.6
5.5 or 6.0
5.1
5.1

10.0
10.0
10.6
10.6
10.0
10.0
10.0
-

8.6
8.5
8.9
9.0
8.6
8.6
8.5
7.8

7.8

2

7.8
-

10.0
10.0

8.5
7.8
8.5

9.0
-

2
1
2
2
1
1
1
2

-

1

75

5.5

-

9.0

-

1

75

5.1

10.0

8.5

-

1

ADA: American Diabetes Association, ADIPS: Australian Diabetes in Pregnancy Society, BSD:
Brazilian Society of Diabetes, CDA: Canadian Diabetes Association, C & C: Carpenter & Coustan,
EASD: European Association for the Study of Diabetes, DIPSI: Diabetes in Pregnancy Study Group
in India, FPG: Fasting Plasma Glucose, JDS: Japan Diabetes Society, NDDG: National Diabetes
Data Group, NZSSD: New Zealand Society for the Study of Diabetes, NICE: National Institute for
Health & Care Excellent, NS: Not specified, SOGC: Society of Obstetricians and Gynecologists of
Canada, WHO: World Health Organization
Source: Adapted from (Agarwal et al, 2015)

1.3.3 Epidemiology of Gestational Diabetes Mellitus

1.3.3.1 Worldwide and European Countries

GDM is a common condition that is estimated to affect 1 - 14% of pregnant
women (ADA, 2015). According to recent estimates, the burden of both GDM and
diabetes is increasing worldwide (Wild et al., 2004; Feig et al., 2008). However, it is
difficult to estimate the prevalence of GDM due to the choice and timings of the
diagnostic tests and socio-demographic and environmental factors of the population
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under study (Bener et al., 2013; Agarwal et al., 2005). In European countries, the
prevalence of GDM ranges between 2 and 6%.

In the United States of America (USA) 7% of pregnant women are affected
by GDM with more than 200,000 cases every year. In addition, two studies showed
that incidence of GDM in multi-ethnic women in the USA increased from 4% in
1991 to 6% in 2002 (Olsen et al., 2016; Buchanan et al., 2012).

1.3.3.2 Asia and Middle Eastern Countries

Research suggests that the burden of GDM is higher in Asian women than
European and American women. A study conducted in New York documented that
South Asian women (Pakistani, Indian, Sri Lankan) had a higher prevalence of GDM
than South East Asian (Malaysian, Thai, Cambodian, Filipino) and East Asian
women (Japanese, Chinese, South Korean, Taiwanese) (Savitz et al., 2008). Another
study conducted in Australia showed that South Asian women had the highest rate of
GDM (69%) of other ethnic groups (Girgis et al., 2012). According to a review, the
prevalence of GDM ranged from 3 to 21% in Asian women (Yuen & Wong, 2015).
In China and India, GDM is reported to affect 13.9% and 14.3% of women (Alzaim
& Wood, 2013).

The burden of GDM in Middle Eastern Countries is reported to be among the
highest in the world. In Bahrain, the incidence of GDM has increased from 7.2% in
2002 to 12.5% in 2010 (Rajab et al., 2012). The burden of GDM has been reported as
the highest (36.6%) in Saudi Arabia, while it was 16% in Qatar and 12 - 25% in the
UAE (Al-Rubeaan et al., 2014; Bener et al., 2011; Agarwal et al., 2010).
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1.3.4 Complications of Gestational Diabetes Mellitus

Gestational Diabetes increases the risk of various immediate and long-term
complications in pregnant women and their offspring. Some of the major
complications are discussed below.

1.3.4.1 Type 2 Diabetes Mellitus

It is well established that women with GDM are at increased risk of developing
type 2 Diabetes in later years. A study reported that approximately 10% of women
with GDM develop type 2 diabetes soon after the delivery and 20 - 60% develop type
2 diabetes within 5 to 10-year period after the pregnancy (Buchanan et al., 2012). A
meta-analysis conducted on Caucasian and mixed population documented that the
risk of diabetes was seven fold higher in women with GDM (Bellamy et al., 2009).
In another systematic review of twenty eight epidemiological studies, the cumulative
incidence of type 2 diabetes among pregnant women was found between 3 and 72%
soon after the delivery and 42% after eight years of pregnancy (Kim et al., 2002).

1.3.4.2 Cardiovascular Diseases (CVDs)

Studies have consistently shown a significant relationship between GDM and
CVDs. A matched case control study on pregnant women showed that women with
GDM were at 51% higher risk of developing CVDs as compared to women without
GDM (Fadl et al., 2014). Another population based study found 25% higher risk of
CVDs in women with GDM compared to those without GDM (Goueslard et al.,
2016). According to Shah and others women with GDM were at 70% higher risk of
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developing coronary and cardiovascular events than women without GDM (Shah et
al., 2008).

1.3.4.3 Metabolic Syndrome

Some evidence suggests positive association of GDM with metabolic syndrome
(constellation of insulin resistance, hypertension and dyslipidemia). For instance, a
meta-analysis of seventeen studies conducted in 2014 demonstrated 3.96 (95% CI:
2.99 - 5.26) higher odds of metabolic syndrome in women with GDM as compared to
those not having GDM (Xu et al., 2014). In a follow up study of pregnant women,
the risk of developing metabolic syndrome as per Adult Treatment Panel III criteria
(presence of ≥ 3 risk factors) was 2.3 times higher in women with GDM than those
without GDM (Gunderson et al., 2009).

1.3.4.4 Macrosomia in Offspring

Women with GDM are more likely to give birth to macrosomic babies, which
increases risk for shoulder dystocia, bone fractures and nerve palsies (Buchanan et
al., 2012). A cohort study conducted in Qatar reported that 10% of women with
GDM gave birth to macrosomic babies versus 6% in non-GDM women (p = 0.01)
(Bener et al., 2011).

1.3.4.5 Type 2 Diabetes in Offspring

Literature shows that offspring of women with GDM are at increased risk of
glucose intolerance and type 2 Diabetes. According to a systematic review, nearly
half (47%) of the cases of diabetes in youth can be attributed to GDM (Veeraswamy
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et al., 2012), while another study showed that hyperglycemia in utero in Pima Indian
women led to diabetes in 40% of their children (5 - 19 years) (Reece et al., 2009).

1.3.4.6 Obesity in Offspring

GDM is shown to increase the likelihood of obesity in children, adolescents
and adults. In Pima Indian population, higher average body mass index (BMI) was
observed in offspring aged 6 - 24 years who were born to women with GDM as
compared to the offspring of women without GDM (p = 0.003) (Dabelea et al.,
2005). Similarly, compared to 409 children of non-diabetic and non-GDM mothers,
average BMI was significantly higher in 95 children (10 - 13 years) who were born
to mothers with GDM and type 2 Diabetes (Crume et al., 2011).

1.3.5 Risk Factors of Gestational Diabetes Mellitus

1.3.5.1 Maternal Age

High maternal age is a significant risk factor of GDM. According to Reece et
al. the risk of developing GDM was 7 - 10 times higher in pregnant women who
were older than 24 years than those younger than 24 years (Reece et al., 2009). A
retrospective cohort study of 656 women reported higher incidence of GDM in
women aged 35 years and above versus younger women (18.6% vs 11.1%, p = 0.01)
(Cozzolino et al., 2017). Similarly, another study showed a significant positive
association of advancing maternal age, pre-pregnancy body mass index, family
history of diabetes with GDM in Chinese women (Leng et al., 2015).
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1.3.5.2 Race and Ethnicity

Studies have found that some ethnic groups are at a higher risk of developing
GDM. Asian women are considered among the high-risk group of developing GDM.
For instance, a longitudinal study conducted in the USA found that women who were
from India, Middle East and Latin America were at a higher risk of developing GDM
than other nationalities (Dode & Dos Santos, 2009). Similarly, according to another
study from the USA, the age adjusted prevalence of GDM was the highest in Asian
Indian (11%), Filipinos (9.6%) and South East Asian (8.8%) women and the lowest
in White (4.2%) and Black (4.4%) women (Hedderson et al., 2010). Another study
conducted in New York concluded that burden of GDM was higher in South Asian
women than other nationalities that include South East Asian and East Asian women
(Savitz et al., 2008).

1.3.5.3 Obesity

Obesity is considered as a strong risk factor for GDM. Moreover, a large body
of evidence claims that GDM is increasing worldwide largely due to parallel rise in
the burden of obesity. Studies have shown that obese women (BMI ≥ 30 kg/m2) are
at 3 times (p < 0.001) higher risk for developing GDM as compared to non-obese
women (Reece et al., 2009; Hunt & Schuller et al., 2007). According to the results of
a systematic review and a meta-analysis of eight studies, women with excessive
weight gain were 40% (p < 0.001) more likely to develop GDM as compared to those
without excessive weight gain (Rajab et al., 2012).
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1.3.5.4 Family History of Type 2 Diabetes

Positive family history of type 2 Diabetes is an important risk factor of GDM.
As reported by Cypryk and colleagues, 40% of women with GDM had a first degree
relative with diabetes (p < 0.05) (Cypryk et al., 2008). While another study
ascertained that positive family history of diabetes increased the risk of GDM by
115% (Yang et al., 2009). This relationship is further supported by the positive
findings of a meta-analysis (Moosazadeh et al., 2017).

1.4 Overview of Vitamin D

Vitamin D is a fat-soluble hormone that exists in two major forms. Vitamin D2
or Ergocalciferol is synthesized by yeasts and fungi and is naturally present in foods
like fish, egg yolk, mushroom and dairy products. Vitamin D3 or Cholecalciferol is
synthesized in the skin of mammals from 7-dehydrocholesterol by the exposure to
ultraviolet B (UVB) irradiation. Vitamin D is biologically inert and requires
hydroxylation for the activation. In the first step, vitamin D is converted to 25hydroxyvitamin D 25(OH)D in the liver, also known as calcidiol. In the second step
1,25-dihydroxyvitamin D (1,25(OH)2D) or calcitriol is produced in kidneys. These
active forms of vitamin D are used as indicators of vitamin D status in the body
(Dalgård, Petersen, Weihe, & Grandjean, 2011a). Vitamin D obtained from the food
fulfills 10% of body‘s requirement of vitamin D while 90% of its requirement are
met by the sunlight (Wagner et al., 2012).
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1.4.1 Functions of Vitamin D

Vitamin D plays an essential role in maintaining various functions of the body.
It helps in mineralization of bones by increasing the absorption of calcium and
blocking the release of parathyroid hormone. It also regulates immune function, cell
proliferation and cellular differentiation (Lips et al., 2010). In addition, it maintains
normal insulin sensitivity by stimulating the secretion of insulin from the pancreas
(Al-Shoumer & Al-Essa, 2015).

1.4.2 Recommended Intake of Vitamin D in Pregnant Women

There is a controversy over the ideal daily intake of vitamin D in pregnancy. In
2011, the Institute of Medicine Committee (IOM) recommended dietary intake of
600 IU of vitamin D per day in pregnancy (Institute of Medicine (US) Committee to
Review Dietary Reference Intakes for Vitamin D and Calcium, 2011). As per
recommendations of the Food and Nutrition Board, both pregnant and non-pregnant
women aged less than 50 years are advised to take 200 IU of vitamin D per day
(Mulligan et al., 2010). According to another study, 5000 IU/day are necessary to
maintain normal vitamin D status in the body (Barrett & McElduff, 2010). In
Scandinavia, pregnant women are advised to take 400 IU of vitamin D daily to
maintain its adequate status of 25 nmol/l. In the USA and Canada, the daily
recommended intake of vitamin D is 600 IU (Mulligan et al., 2010).

In the UAE and other gulf countries, guidelines for vitamin D supplementation
have been developed recently. According to these guidelines, pregnant and breast
feeding women are advised to take 1500 - 2000 IU of vitamin D daily (Haq et al.,
2016). Besides setting up these guidelines, other initiatives such as fortification of
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cooking oil, milk and milk products with vitamin D have been launched by the
country to improve vitamin D levels in the population (Wimalawansa et al., 2013).
However, various issues have been reported with these initiatives, which might be
hampering their effectiveness. For instance, a study conducted in Al Ain in 2011
reported that the level of vitamin D fortification was not mentioned on the labels of
oils. The study also found that 87% of milk products were fortified with vitamin D;
however, only 39% of these fortified samples had the adequate levels (0.8-1.2
µg/100 ml) of vitamin D, 31% were under fortified and 30% were over fortified
(Laleye et al., 2011). Although, this study has pointed out important issues in the
fortification of food products, more research is required to support these claims.

1.4.3 Diagnosis of Vitamin D Deficiency and Insufficiency

Various guidelines exist to diagnose vitamin D deficiency and insufficiency.
These guidelines vary with respect to cut-off points that are used to diagnose vitamin
D deficiency and insufficiency (Kennel et al., 2010). The existence of multiple
guidelines presents a major challenge in estimating and comparing the burden of
vitamin D deficiency within and across populations. Also, it considerably affects the
clinical management of vitamin D deficiency.

Two widely used guidelines for diagnosing vitamin D deficiency are those
developed by (IOM) and the Endocrine Society Clinical Practice (Holick et al.,
2011; Ross et al., 2011). The cut-off points for vitamin D concentration 25(OH)D
recommended by these guidelines are elaborated in Table 1.3.
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Table 1.3: Serum 25-Hydroxyvitamin D [25(OH)D] concentrations and vitamin D
deficiency
25(OH)D concentration
nmol/L
ng/ml

Vitamin D status

Institute of Medicine
<30.0
30.0-50.0
≥50.0
>125.0

<12.0
12.0-20.0
≥20.0
>50.0

Deficiency
Insufficiency
Adequate/Sufficiency
High levels

The Endocrine Society Clinical Practice
<50.0
52.5-72.5

<20.0
21.0-29.0

Deficiency
Insufficiency

≥75.0

≥30.0

Adequate/Sufficiency

Source: (Ross et al., 2011; Holick et al., 2011)

1.4.4 Epidemiology of Vitamin D Deficiency and Insufficiency

1.4.4.1 Worldwide and European Countries

Vitamin D deficiency is a global health problem. Approximately, one billion
people worldwide are estimated to have vitamin D deficiency, while 50% have
vitamin D insufficiency (Nair & Maseeh, 2012). In the US and Europe more than
40% of adults are vitamin D deficient.

Compared to the general population, vitamin D deficiency is more common in
pregnant women due to increased demands of vitamin D in pregnancy (Dawodu et
al., 2003; Seth et al., 2009). However, its prevalence varies remarkably across
countries and continents due to various factors. Studies from the US, Australia, South
Asia and the Middle East have reported that 20 - 98% of women develop vitamin D
deficiency during pregnancy, while 66 - 100% develop vitamin D insufficiency
(Narchi et al., 2010; Dalgård et al., 2011). Similar to these studies, a review
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documented that 40 - 98% of women have vitamin D levels < 50 nmol/L (Dawodu &
Wagner, 2007).

1.4.4.2 Asia and Middle Eastern Countries

There is some evidence that the levels of vitamin D are generally lower in
Middle Eastern and South Asian women because of decreased dietary intake of
vitamin D and inadequate sunlight exposure (Saadi et al., 2010; Nair & Maseeh,
2012; Eggemoen et al., 2016). A study conducted in Saudi Arabia found that 50% of
pregnant women had vitamin D deficiency (Al-Faris et al., 2016). While several
studies from other Middle Eastern countries have documented that the prevalence of
vitamin D deficiency ranges between 10% and 60% (Dawodu et al., 2003; Bener, et
al., 2013; Al-Mohaimeed et al., 2012).

Consistent with regional estimates, vitamin D deficiency is a major problem in
the UAE. According to recent estimates, vitamin D deficiency effects 37 - 65% of
the Emirati population (Laleye et al., 2011). Similar to the general population, a high
proportion of pregnant women are vitamin D deficient in the country. A prospective
study (75 women) showed that 69% of Emirati pregnant women were vitamin D
deficient (< 10 ng/ml) (Narchi et al., 2010).

1.4.4.3 Consequences of Vitamin D Deficiency and Insufficiency

Inadequate levels of vitamin D are associated with various adverse health
outcomes. Vitamin D deficiency increases the risk of osteoporosis and rickets
(Holick & Chen, 2008). In pregnant women vitamin D deficiency may lead to
preeclampsia, miscarriage, cesarean section and pre-term birth. In utero or early life,
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inadequate levels of vitamin D increase the risk of neonatal hypocalcaemia, rickets,
type 1 diabetes, asthma and schizophrenia (Nair & Maseeh, 2012; Aghajafari et al.,
2013).

1.4.4.4 Risk factors of Vitamin D Deficiency and Insufficiency

Age

Vitamin D deficiency influences all age groups. Nevertheless, elderly people are
at higher risk of developing vitamin D deficiency because their skin loses efficiency
to synthesize vitamin D, they have inadequate intake of vitamin D and spend more
time indoors (Lips et al., 2010; Nair & Maseeh, 2012).

Sex

Studies have shown that females are more likely to develop vitamin D
deficiency than males particularly in Middle East countries where women cover their
most of the body parts and do not get frequent exposure to sunlight (Verdoia et al.,
2015).

Skin Pigmentation

Synthesis of vitamin D is associated with skin pigmentation. Melanin in the
skin scatters UVR-B and delays the conversion of 7-dehydrocholesterol to previtamin D3. Therefore, synthesis rate of vitamin D is slower in people with dark skin
as compared to light-skinned people. In light-skinned adults, full exposure to the sun
till skin turns slightly pink would generate 10,000 - 20,000 IU of vitamin D within 24
hours of exposure. In contrast, people with dark skin need ten times more exposure
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to generate the same amount of Vitamin D (Bonilla et al., 2014; Nair & Maseeh,
2012).

Clothing Style

Clothing could influence the synthesis of vitamin D from the skin. In the
Middle East, Africa and other Muslim countries, women practice of veil limits their
exposure to sunlight. Various studies have demonstrated veil as an independent
factor of vitamin D status (Lips et al., 2010; Saadi et al., 2007).

Latitude and Seasonality

Vitamin D levels differ according to the latitude. People living in Northern
latitudes are more vitamin D deficient than those living in southern latitudes. Climate
type and seasons also affect the levels of vitamin D (Holmes et al., 2009). In winter,
vitamin D deficiency is higher than the summer in northern latitudes. In the UAE, the
situation differs as in the summer vitamin D deficiency is more frequent compared to
the Winter season because people avoid the sun in the summer (Al Anouti et al.,
2011).

Diseases and Drugs
Some diseases such as liver disease, cystic fibrosis and Crohn‘s disease can
cause vitamin D deficiency by affecting the metabolism and absorption of vitamin D.
Also, the chronic use of steroids, immune-suppressants, anticonvulsants, rifampicin,
and antiretroviral drugs can also affect the metabolism and absorption of vitamin D
and calcium (Nair & Maseeh, 2012).
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Dietary Consumption of Vitamin D

Research has demonstrated that the foods rich in vitamin D such as fatty fish
and cod liver oil are consumed more by some countries like Sri Lanka and Vietnam
as compared to Pakistanis (Lips et al., 2010).

1.5 Literature Review

1.5.1 Association Between Vitamin D Deficiency and GDM

1.5.1.1 Worldwide

Research suggests that vitamin D deficiency may contribute to the
development of GDM (Burris et al., 2012; Lacroix et al., 2014; McElduff et al.,
2008). However, the exact mechanism of association is unclear. Some literature
describes that vitamin D is essential for maintaining insulin sensitivity and glucose
homeostasis by enhancing insulin sensitivity and secretion. Also, it plays an
important role in stimulating insulin receptors and taking glucose in adipose cells and
muscles. Furthermore, it helps in reducing the inflammatory process that decreases
the functional capacity of pancreatic ß-cells. Therefore, the deficiency of vitamin D
may cause dysfunction in pancreatic ß-cells and impair the function and uptake of
insulin (Joergensen et al., 2014; El Lithy et al., 2014).

The epidemiological evidence regarding the association between vitamin D
deficiency and risk of GDM is contradictory. Numerous studies from various parts of
the world have shown a positive association between these conditions. For instance,
in 2015, a meta-analysis of twenty observational studies that included 9209
participants concluded that pooled odds of GDM were 1.53 (95% CI: 1.33-1.75)
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times in women with vitamin D deficiency as compared to women with no
deficiency (Zhang et al., 2015). Two other meta-analysis of thirty-one and seven
studies showed that pooled odds of GDM were 1.49 (95% CI: 1.18-1.89) and 1.61
(95% CI: 1.19 - 2.18, p = 0.002) respectively in women with insufficient vitamin D
versus women with sufficient levels (Aghajafari et al., 2013; Poel et al., 2012). A
cross-sectional study conducted in a hospital in Turkey reported a significant
association of severe vitamin D deficiency with GDM (Zuhur et al., 2013).
Moreover, according to a review, seven large observational studies conducted in
Iran, Korea, China and Arab Countries reported a significant association between
vitamin D deficiency and GDM (Joergensen et al., 2014).

In contrast, some studies have shown no association between GDM and vitamin
D. A meta-analysis that included thirteen randomized control trials found similar risk
(RR: 0.88, 95% CI: 0.5 - 1.52) of GDM in both vitamin D deficient and non-deficient
groups (Pérez-López et al., 2015). A prospective cohort study of 310 women carried
out in Madigan Army Medical Center in Washington, USA claimed that association
between vitamin D deficiency and GDM was insignificant (Adjusted OR:2.60, 95%
CI: 0.28-27.4) (Flood-Nichols, et al., 2015). Similar to observational studies, a
double randomized control trial failed to find a significant difference in the incidence
of GDM in women who received 5000 IU (10.5%) of vitamin D in pregnancy versus
those who received 400 IU daily (13%) (Yap et al., 2014).

1.5.1.2 Middle East and the UAE

Like other countries, studies carried out in the Middle East have reported
conflicting findings concerning the association between GDM and vitamin D

21
deficiency. In addition, only a few cohort studies have been carried out in the region
and none in the UAE to examine the relationship between these intricate problems.

A cross-sectional study conducted in Egypt on 160 pregnant women aged 2440 years found that average vitamin D levels were not significantly different between
vitamin D deficient and non-deficient groups (47.3 ± 10.2 vs 46.6 ± 6.1) (El Lithy et
al., 2014). Another case-control study conducted in Turkey including 122 pregnant
women (44 with GDM and 78 non-GDM), did not find any correlation of serum
vitamin D with serum fasting glucose (p = 0.9), insulin levels (p = 0.2) or HbA1c
levels (p = 0.1) (Ates et al., 2017).

Conversely, a cross-sectional study in Iran found significant inverse
associations between serum level of 25(OH)D and HbA1c at the beginning of the
pregnancy (p < 0.001), insulin levels in the second trimester (p = 0.004) and blood
sugar (p = 0.045) after consuming 75 g glucose. Likewise, another study in Iran
noted a significant difference in vitamin D levels among GDM and normal groups
(16.5 ± 10.4 vs 23.0 ± 18.3, p < 0.001) (Maghbooli et al., 2008; Jafarzadeh et al.,
2015). In Qatar, a cohort study of 1,873 Arab pregnant women above 24 weeks‘
gestation showed that women with vitamin D deficiency 25(OH) D < 10 ng/ml) had
higher odds of GDM (odds ratio: 1.4, 95% CI: 1.1 - 11.8, p = 0.019) as compared to
those without GDM (Bener et al., 2011).

1.5.2 Association between Diet and GDM

Diet is known to have a profound effect on the development of GDM during
pregnancy. Therefore, the role of diet during pregnancy and in GDM has been
explored extensively by clinical and epidemiological studies worldwide.
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1.5.2.1 Red Meat

Studies have found that consumption of large amount of red and processed
meat is found to be positively correlated with GDM, as cholesterol and saturated fats
in the meat negatively affect insulin sensitivity and ß-cell function of pancreas,
which may cause GDM. In addition, nitrates which are regularly used as preservative
in processed meat are linked to the development of type 2 diabetes (Bao et al., 2014;
Zhang & Ning, 2011). According to a cohort study, increasing intake of red and
processed meat by one serving per day, elevated the risk of GDM by 61 and 64%
respectively (C. Zhang et al., 2006). Also, a systematic review of ten prospective, six
cross-sectional and five case-control studies also reported a positive association
between higher consumption of red and processed meat with GDM (Zhang et al.,
2015).

1.5.2.2 Dietary Fiber and Vegetables

Dietary fiber, which include cereal, vegetables and fruit fiber has been found
beneficial in reducing the risk of GDM because these foods have low glycemic index
and therefore can achieve better glucose control by decreasing the postprandial
glycaemia and slowing down the absorption rate of the carbohydrates (Schulze et al.,
2004). As per findings of a study, increasing intake of total fiber by 10g per day
decreased the risk of GDM by 26% (95% CI: 9% - 49%), while 5g increment in
cereal or fruit fiber per day decreased the risk of GDM by 2.15 folds as compared to
common diet consumption (Zhang & Ning, 2011). A few studies have also shown the
positive impact of Low Glycemic Index (LGI) on maternal fasting glucose levels and
reducing risk of macrosomia (Moses et al., 2009; Louie et al., 2010). A cohort study
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from China reported that the consumption of vegetables decreased the risk of GDM
(He et al., 2015). While the Nurse‘s Health Study II noticed an inverse association
between prudent dietary pattern (fruits, green leafy vegetables, poultry, fish) and
GDM (Zhang et al., 2006). According to the findings of another cohort study,
pregnant women who adhered to Mediterranean diet during pregnancy had a lower
incidence of GDM and better glucose tolerance than those who did not adhere to
Mediterranean diet (Karamanos et al., 2014).

1.5.2.3 Fatty Diet

The consumption of diet rich in fat has been linked to the increased risk of
GDM. A cohort study claimed that a high fat and low carbohydrate diet is associated
with increased risks of glucose intolerance and GDM (Bao et al., 2014). In the cohort
study from Italy, the consumption of saturated fats was found to play an independent
role in the development of GDM even in the absence of classical risk factors of
GDM (Bo et al., 2001). Similarly, another cohort study reported a significant
association of high intake of fat and cholesterol during pregnancy with the risk GDM
(Bowers et al., 2012). Additionally, a study demonstrated that replacing carbohydrate
with fat (per 1% of total calories) elevated the risk of GDM by 10% (Saldana et al.,
2004).

1.5.2.4 Sweets and Sugar Beverages

The consumption of sweets and sugar beverages during pregnancy is positively
associated to GDM. According to the Nurse‘s Health Study II, women who drank
more than 5 servings of sweetened cola were at 22% higher risk of developing GDM
than those who drank less than 1 serving (Chen et al., 2009). A study from China
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revealed that intake of sweets during pregnancy increased risk of GDM by 23% (He
et al., 2015).

1.5.3 Association Between Physical Activity and GDM

Exercise improves insulin sensitivity and glycogen synthesis, which results in
lower glucose concentrations in the blood. Therefore, exercise is considered as an
effective intervention in reducing the risk of type 2 Diabetes (Dempsey et al., 2004;
Davenport et al., 2008). However, the evidence regarding the effect of exercise on
GDM is conflicting with the majority of studies demonstrating a significant effect of
exercise on lowering the risk of GDM. For instance, an observational study
mentioned that the risk of GDM is reduced by 20 - 55% in those women who are
engaged in various forms and intensities of physical activity during and before
pregnancy (Redden et al., 2011). In addition, a prospective study of 909 women
showed that women who participated in any vigorous physical activity prior 12
months of their pregnancy had a 56% lower risk of developing GDM (Dempsey et
al., 2004). Another study claimed that women who participated in any vigorous
physical activity twelve months before pregnancy had a 44% lower risk of
developing GDM as compared to inactive women during the same period (Oken et
al., 2006). Similarly, two systematic reviews concluded that physical activity
intervention reduced the likelihood of GDM by 28 and 33% respectively (Russo et
al., 2015; da Silva et al., 2016). In contrast to these studies, a review of thirteen
randomized control trials showed an insignificant difference in the risk of developing
GDM (RR: 0.92, 95% CI :0.68 - 1.23) between intervention (diet and exercise) and
control group (Bain et al., 2015).
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Research suggests that amount of physical activity is decreased considerably
during pregnancy most probably due to symptoms of nausea and fatigue in early
pregnancy and perceived risk to maternal and fetal health (Perichart-Perera et al.,
2009). That is why, the Canadian Diabetes Association (CDA) encourages obstetricrisk tailored physical activity during pregnancy, while the American College of
Obstetricians and Gynecologists (ACOG) advises 30 minutes of moderate physical
activity on most days of the week (Chasan-Taber et al., 2011).

To our knowledge, no published data on physical activity in pregnant women
are available in the UAE. However, a cross-sectional study carried out in 2009 on
Emiratis mentioned that only 30% of Emirati females walked for at least 30 minutes
3 times per week (Al-Kaabi et al., 2009).
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Chapter 2: Methods
2.1 Aims and Objectives

2.1.1 Aims

The overall aim of this study was to improve understanding about risk factors of
GDM and the relationship between vitamin D deficiency and GDM in Emirati
population. The findings of this study will guide health regulatory authorities and
stakeholders in designing evidence based guidelines and interventions for screening,
preventing and managing GDM in the UAE. Also, these findings will help clinicians
in the early identification of high risk women and better management and prevention
of GDM and its complications.

2.1.2 Objectives

2.1.2.1 Primary Objectives

-

To estimate the incidence of GDM in Emirati pregnant women.

-

To investigate whether vitamin D deficiency in early pregnancy (≤ 15 weeks
of gestation) is associated with an increased risk of developing GDM in
Emirati pregnant women.

2.1.2.2 Secondary Objectives

-

To examine the association of physical activity before pregnancy with the
development of GDM in pregnant Emirati women.

-

To explore what type of diet consumed during early pregnancy is associated
with an increased risk of GDM in pregnant Emirati women.
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-

To identify significant risk factors of GDM in pregnant Emirati women.

2.2 Study Design

A prospective cohort study design was adopted to estimate the incidence of
GDM and to investigate the effect of vitamin D deficiency, physical activity, diet and
other risk factors on the incidence of GDM. This study design has many advantages
over other observational designs. First, it allows estimating the incidence of disease.
Second, this design is useful in investigating multiple risk factors of diseases. Third,
it enables to establish the temporal relationship between an exposure and outcome.
Last, a well-designed cohort study can control for confounding factors and recall bias
(information bias) as we used FFQ and GPAC questionnaires and the participants
were asked about their family history of diabetes. One of the most important
confounding factor to this study is the body mass index, family history of Diabetes
and vitamin D supplements which have adjusted during the analysis by using logistic
regression (Sedgwick et al., 2013).

2.3 Study Site

The study was conducted in Ras Al Khaimah (RAK), which is one of the
seven Emirates of the UAE as it was the best destination for the principle
investigator who is from RAK and no studies have been carried out on this issue in
RAK. In 2015, the total population of RAK was estimated to be 345,000 (RAK
Center for Statistics, 2015)

A total of eighteen primary healthcare centers are located in RAK were
selected to present the whole city form East to West and South to North. These
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clinics belong to the RAK medical district and operate under the umbrella of
Ministry of Health. The clinics are designated to provide dental treatment, general
treatment, mother and child health services, comprehensive antenatal care and
nursing services to both Emirati and expatriate population. In 2015, a total of
858,850 people visited these clinics among which 21981 were antenatal visits
(Statistics Department, Ras Al Khaimah Medical District [Ministry of Health],
2015).

2.4 Study Population

We chose eight primary healthcare centers from various parts of the Emirate that
were more frequently utilized for antenatal care. The study population comprised
Emirati pregnant women who visited these primary healthcare centers for antenatal
care between March 2014 and July 2015. A total of 5918 pregnant women sought
antenatal care at these clinics during that period (Statistics Department, Ras Al
Khaimah Medical District [Ministry of Health], 2015).

2.5 Selection of Study Participants

2.5.1 Inclusion Criteria
The following inclusion criteria were used to select study participants;
-

Emirati women who were living in RAK.

-

Those women who were aged between 18 and 45 years.

-

Women who were ≤ 15 weeks of gestation.
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2.5.2 Exclusion Criteria

The following criteria were used to exclude study participants;
-

Women who were younger than 18 years and/or older than 45 years.

-

Women who initiated antenatal care after 15 weeks of pregnancy.

-

Women with non-singleton pregnancies.

-

Women who had previous history of GDM.

-

Women who had a positive history of type 1 and type 2 Diabetes mellitus.

-

Women who had abnormal liver function and/or hepatitis

-

Women who had Human Immunodeficiency Virus (HIV)

-

Women who had impaired kidney function

The researcher determined the eligibility of participants by reviewing their
medical records followed by interviews to confirm their eligibility. Out of the total
(800) women who were screened at selected eight clinics between March 2014 and
July 2015, 700 women met the inclusion criteria, while 622 agreed to participate in
the study. For an overview of selection process, (see Figure 2.1).
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Total numbers of pregnant women screened in the 8 health care centers
between 3.2014 and 7.2015 (n=800)

700 met the eligibility criteria for recruitment

622 women consented to participate in the study

600 women were interviewed/records were accessed

563 women completed the study
Figure 2.1: Flow chart of selection procedure of study participants

2.6 Sample Size Calculation

A sample of 507 participants (169 exposed and 338 non-exposed) was required
to detect with an 80% power, a relative risk of 1.8. This minimal relevant relative
risk value was based on the study by Wang and others who showed that subjects with
25(OH)D level < 25 nmol/l had a 1.8-fold higher risk of developing GDM than those
with 25(OH) D level ≥ 25 nmol/l. We assumed that 10% of non-exposed women (i.e.
without vitamin D deficiency) would have GDM during their follow-up. This
assumption was based on the data by (Agarwal et al., 2010), who had shown that the
prevalence of GDM in the UAE was 13% including both exposed (vitamin D
deficient) and non-exposed women. The sample size was calculated using the
function epi.studysize from the package epiR of the statistical software R version
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3.0.2 (R Development Core Team et al., 2008). The probability of type 1 error (α)
was set to 5% and the sample ratio of exposed to unexposed was set to 2. This choice
of unexposed to exposed ratio was based on the finding by Saadi et al. (2010), that
the proportion of women with a Vitamin D level in the UAE less than 25 nmol/l (i.e.
exposed women) was 35.1%.

2.7 Study Measurements

2.7.1 The Outcome Variable

Gestational diabetes was the outcome variable in this study. In RAK primary
healthcare centers, GDM is diagnosed in 24 - 28 weeks of gestation by using the
two-step approach. In the first step, fasting blood glucose (FBG) of women is
measured. Those women who are not fasting are asked to fast for at least 10 hours
and come back the next day for the FBG test. In the second step, 75 g OGTT is
administered to measure 2-hour postprandial blood glucose.

In this study, we obtained the data of FBG and OGTT and adopted the WHO
(2013) to diagnose GDM. According to these criteria, GDM was defined as having
fasting blood glucose ≥ 5.1 mmol/l or a 2-hour postprandial glucose ≥ 8.5 mmol/l in
24 - 28 weeks of gestation.

2.7.2 The Primary Exposure Variable

The primary exposure variable was vitamin D deficiency in the first trimester of
pregnancy. At baseline, serum concentration of vitamin D metabolites were
determined by radioimmunoassay kits from immunodiagnostic systems Cobas e-411
from Roche Company USA. As per IOM criteria, vitamin D insufficiency was
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defined as serum concentration of 25(OH)D 30-50 nmol/L or 12 - 20 ng/ml and
deficiency as serum concentration of 25(OH)D < 30 nmol/L or < 12 ng/ml (Ross et
al., 2011) (See Table 1.3 for the cut-offs of vitamin status).

2.7.3 Other Measurements

2.7.3.1 Socio-demographic Characteristics

In socio-demographic characteristics information about age, household size,
level of education, occupation, income, marital status and medical history was
collected at baseline. (See Appendix 1 for details).

2.7.3.2 Anthropometric Indicators

Anthropometric indicators included height, weight and body mass index (BMI)
before and during pregnancy. At baseline, height was measured in centimeters (cm)
and weight in kilograms (kg) by using SACA machine. The BMI (kg/m2) was
calculated by dividing the weight in kg with height in square meters. Obesity was
defined as BMI ≥ 30 kg/m2 and overweight as BMI ≥ 25 - 29.9 kg/m2 by using the
cut-offs recommended by the World Health Organization (WHO, 2004) (See
Appendix 1 for details).

2.7.3.3 Blood Pressure

Systolic and diastolic blood pressure measurements were taken at baseline by
using Welch Allyn 53000 sphygmomanometers. High blood pressure was defined as
systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥ 90 mmHg by using
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the National Institute for Health and Clinical Excellence (NICE) guidelines (NICE,
2016) (See Appendix 1 for details).

2.7.3.4 Physical Activity

The physical activity during the last seven days was measured at baseline by
using The Global Physical Activity Questionnaire (GPAQ) (―Global Physical
Activity Questionnaire,‖ n.d.). The GPAQ is an internationally validated tool that is
developed by the WHO. It subjectively collects information on physical activity over
the past week at work; travel to and from places and recreational activities as well as
sedentary behavior. It comprises 16 questions which cover vigorous and moderate
activity at work, transport activity, vigorous and moderate activity during leisure
time and sitting time. (See Appendix 2 for details). The intensity of physical activity
is expressed in Metabolic Equivalents (METs), which is defined as the ratio of
working metabolic rate relative to the resting metabolic rate. The METs were
calculated by following the GPAQ guidelines and low activity level was defined as
METs < 600 per week. In addition, the amount of physical activity performed during
the last seven days was categorized into ‗low‘, ‗moderate‘ and ‗high‘ physical
activity by following the GPAQ guidelines.

2.7.3.5 Dietary Intake

The dietary intake was measured by using a validated Food Frequency
Questionnaire (FFQ). It is one of the most commonly used tools in epidemiologic
studies to assess long-term nutritional exposure and to study the relationship between
diet and chronic diseases. A short version of FFQ abbreviated as SFFQ has been
developed for the UAE and Kuwait (Dehghan et al., 2005). We modified some
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questions of SFFQ to adopt it for our study. For each food item, participants
indicated their average frequency of consumption over the past year of a specified
serving size by checking 1 of the 9 frequency categories. We collapsed these
frequency categories into ‗monthly = 1 - 3 times per month ‘, ‗weekly = 1 - 6 times
per week‘ and ‗daily = 1 - 6 times per day‘ consumption of food. Food items were
grouped into nine broad food groups such milk and milk products, fruits, vegetables,
meat and meat products, cereals and cereal products, beverages and sweets and nuts
with the addition of oil and fat used for cooking and preparing the food, number of
meals consumed out of the home and the vitamins and minerals supplements during
the last six months (in addition to vitamin D) (See Appendix 3 for details).

2.8 Data Collection Procedure

The principal investigator received training in data collection from the Ministry
of Health of the UAE. The principal investigator then trained eight nurses in data
collection (one from each primary healthcare centers). Prior to data collection, the
FFQ, GPAQ and socio-demographic questionnaires were translated into Arabic and
pilot tested on a random sample of 25 women. After the piloting, corrections and
modifications were made in questionnaires if needed.

At baseline, the principal investigator and nurses conducted face to face
interviews with 600 study participants to collect the information about sociodemographic characteristics, medical history, physical activity and dietary intake in
pregnancy. In addition, nurses measured blood pressure, height and weight while
phlebotomists drew blood samples to measure fasting blood glucose and vitamin D.
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The blood samples from each health center were transported on the same day to a
tertiary care hospital laboratory for the analysis.

After collecting the baseline information, participants were informed by
physicians to revisit antenatal clinics in their 24 - 28 weeks of gestation. During their
follow-up visit, the blood samples were drawn to screen for GDM. The investigator
assessed the medical records of participants or conducted telephonic interviews to
confirm the presence of GDM during the pregnancy. The attrition rate was 11.2 %.

2.9 Ethical Considerations

2.9.1 Ethical Approval of Study

The study was approved by Al Ain Medical District Human Research Ethics
Committee (AMDHREC), RAK Research Ethics Committee in RAK Medical
District (RAKREC) (See Appendices 4 and 5). The AMDHREC reviews all studies
that are performed on human subjects. The purpose of this committee is to ensure
that human researches meet acceptable standards of scientific merits, ethics, patient
safety and cultural propriety of the UAE.

2.9.2 Informed Consent

Eligible participants were given detailed information about the study and were
assured of strict confidentiality (See Appendix 6). Both oral and written consent were
sought from participants who agreed to participate in the study (See Appendix 7).
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2.9.3 Confidentiality

A unique identification number was assigned to each participant and names were
removed in the data to conceal their identity. Personal information that could identify
participants was kept in a separate computer and was accessed only by the
researcher. All data were stored in the password protected computer. All participants
were assured that their identities will not be disclosed in any publication.

2.10 Timeline

The study was completed in a period of approximately thirty-nine months.
The study was approved in March 2014 and write-up was completed in June 2017.
See Table 2.1 for the detailed timeline of the study.

Table 2.1: Time line of the study

2014
MarMay

Items

JunAug

2015
SepDec

JanMar

AprJun

JulySep

2016
OctDec

JanMar

AprJun

JulySep

2017
OctDec

JanMar

AprJun

Ethical approval
Data collection
Data analysis
Write-up

2.11 Data Analysis

The principal investigator entered the data in IBM Statistical Package for Social
Sciences (SPSS) version 22.0. The data were inspected for inconsistencies, keystroke errors and missing values to ensure its quality. The statistical analysis was
performed in Stata SE version 14.2. In descriptive analysis, qualitative variables
were summarized as frequencies and percentages, while quantitative variables were
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summarized as mean ± standard deviation (± SD). The distribution of age and BMI
before and during pregnancy was shown in histograms. The prevalence of obesity,
high blood pressure, family history of diabetes and vitamin D insufficiency and
deficiency were tabulated as well as presented in bar charts. The incidence of GDM,
overall and by vitamin D status was summarized as frequencies and percentages and
presented as tables and bar charts. Also, the incidence of GDM was cross-tabulated
as

frequencies and

percentages

with

baseline demographic

and clinical

characteristics, physical activity levels and dietary intake. Chi-square and Fischer
Exact tests were applied to compare differences in proportions of GDM status
according to different qualitative variables. Unpaired Student t-tests and Wilcoxon
Rank Sum tests were used to test average and median differences in quantitative
variables by GDM status.

Simple and multiple binary logistic regression analysis were performed to
ascertain the association of vitamin D deficiency, vitamin D status, vitamin D
(continuous), physical activity and diet with GDM and identify other significant risk
factors of GDM. In the first step, the simple logistic regression analysis was
performed to estimate crude odds ratios (COR), confidence intervals (CIs) and p
values of GDM for vitamin D deficiency, diet, physical activity and other risk
factors. In the second step, multiple logistic regression analysis was performed to
estimate adjusted odds ratios (AOR), CIs and p values of GDM for vitamin D
deficiency, diet, and physical activity along with other risk factors that had p values
< 0.10 in simple logistic regression. The p value < 0.05 and 95% CI were chosen to
determine statistical significance. This multiple logistic regression analysis was
repeated for all three types of variables of vitamin D ([vitamin D deficiency vs
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normal vitamin D], [vitamin D insufficiency vs normal vitamin D, vitamin deficiency
vs normal vitamin D], [vitamin D as a continuous variable]).
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Chapter 3: Results
3.1 Recruitment and Follow-up

The entire data collection was completed in a period of twenty-four months
approximately. More specifically, the first participant was recruited in March 2014
and the last participant in July 2015 (See Figure 3.1). The last follow-up was
completed in February 2016.
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Figure 3.1: Recruitment of participants per calendar
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3.2 Baseline Demographic Characteristics

A total of 563 pregnant women completed the study, while the information
regarding the outcome (GDM) was available for 533 women. Sixty-seven women did
not complete the study due to miscarriage before 24 weeks and loss to follow-up.
The mean age of women was 29.5 ± 5.6 years and was approximately normally
distributed (see Figure 3.2). Above half of the women (52.4%) completed the high
school and 36.1% had a college or university degree. The majority of women
(98.9%) were married, three-fourth were housewives (75.5%) and around one fifth
(18%) were working in non-government organizations. Sixty-three percent of the
women had a positive family history of diabetes mellitus (Figure 3.3). (See Table 3.1
for details).
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Table 3.1: Baseline demographic characteristics of women
Variables
n (%) / Mean ±SD
Age – Years, Mean ±SD
29.5 ±5.6
Number of women > 18 years, Median (iqr)
3 (2)
Education level, n (%)
Up to primary
23 (4.1)
Up to secondary
42 (7.5)
Up to high school
295 (52.4)
≥ College/University
203 (36.1)
Marital Status, n (%)
Married
557 (98.9)
Separated/Divorced/Widowed
6 (1.1)
Work Status, n (%)
Government employee
93 (16.5)
Non-government employee
8 (1.4)
self employed
10 (0.2)
Student
36 (6.4)
House wife
425 (75.5)
Monthly income – AED, Median (iqr)
24000 (14000)
Family history of Diabetes Mellitus, n (%)
360 (63.9)
n: Frequency, SD: Standard Deviation, iqr: Interquartile Range, AED: Arab
Emirates Dirham
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Figure 3.2: Distribution of age of women
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Figure 3.3: Family history of diabetes in women

43
3.3 Baseline Clinical Characteristics

The Table 3.2 shows that the mean body mass index (BMI) of women before
pregnancy was 27.2 ± 6.8 kg/m2 and during early pregnancy was 27.8 ± 6.8 kg/m2.
The distribution of BMI before and during pregnancy was slightly positively skewed
due to high values of BMI for some women (See Figure 3.4). Approximately one
fourth (26.5%) of the women were overweight and 30.5% were obese before
pregnancy (see Figure 3.5). The mean systolic blood pressure was 107.1 ± 11.4
mmHg and diastolic pressure was 64.2 ± 9.5 mmHg. A small proportion (1.6%) of
women had a hypertension according to NICE criteria (See Figure 3.6).

Figure 3.4: Distribution of Body Mass index of women before and during early
pregnancy
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Table 3.2: Baseline clinical characteristics of women

Percent (%)

Variables
n (%) / Mean ±SD
Anthropometric indices
Height – cm, Mean ±SD
158 ±5.3
Weight before pregnancy – kg, Mean ±SD
68.1 ±17.4
Weight during pregnancy – kg, Mean ±SD
69.7 ±17.5
2
Body Mass Index before pregnancy – kg/m , Mean ±SD
27.2 ±6.8
Body Mass Index before pregnancy categories – WHO, n (%)
Normal (< 25.0 kg/m2)
242 (43.0)
2
Overweight (25.0 - 29.9 kg/m )
149 (26.5)
2
Obese ( ≥ 30 kg/m )
172 (30.5)
2
Body Mass Index during early pregnancy – kg/m , Mean ±SD 27.8 ±6.8
Blood Pressure – mmHg
Systolic Blood Pressure, Mean ±SD
107.1 ±11.4
Diastolic Blood Pressure, Mean ±SD
64.2 ±9.5
High blood pressure, n (%)
9 (1.6)
n: Frequency, SD: Standard Deviation, OGTT: Oral Glucose Tolerance Test, ADA:
American Diabetes Association, IOM: Institute of Medicine, WHO: World Health
Organization
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Figure 3.5: Prevalence of overweight and obesity in women
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Figure 3.6: High blood pressure in women

3.4 Baseline Physical Activity Levels

Table 3.3 shows that the median (IQR) METs score per week of pregnant
women was 840 (1320) minutes and sedentary time per day was 240 (280) minutes.
Physical activity per day related to work was reported by 6.6% of women, travel by
51.7% and recreation by half (50.4%) of the women. According to the WHO criteria,
below one tenth of the women (8.5%) reported performing high physical activity,
55.6% moderate physical activity, while 35.9% of women reported performing low
physical activity (See Figure 3.7).
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Table 3.3: Physical activity levels of women
Variables
Total METs per week, Median (iqr)
Low physical activity (METs <600 / week), n (%)
Physical activity levels per day, n (%)
High
Moderate
Low
Work related moderate and vigorous physical activity per day, n (%)
Travel physical activity per day, n (%)
Recreational moderate and vigorous physical activity per day, n (%)
Sedentary time per day – minutes, Median (iqr)
n: frequency, iqr: Interquartile Range, METs: Metabolic Equivalents

60

n (%)
840 (1320)
129 (34.4)
46 (8.5)
300 (55.6)
194 (35.9)
37 (6.6)
291 (51.7)
284 (50.4)
240 (280)
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Figure 3.7: Levels of physical activity in women
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3.5 Baseline Supplements and Dietary Intake

Table 3.4 shows the use of vitamin D and other supplements in women at
baseline. Approximately one fifth (19.0%) of the women reported using vitamin D,
multivitamins or / and mineral supplements during the last six months. Of the women
who were using vitamin D supplements, the majority (98.2%) were using these
supplements for a period of less than one year.

Table 3.4: Use of supplements in women
Variables
Use of multivitamins /minerals during the last six months
Duration of using multivitamins/minerals
< 1 year
1-3 years
4-6 years
Vitamin D supplements use during the last six months
Frequency of vitamin D supplements use
< one year
1-3 years
4-6 years
n: Frequency

n (%)
107(19.0)
104 (18.5)
2 (0.4)
1 (0.2)
112 (19.9)
110 (98.2)
1 (0.9)
1 (0.9)

Table 3.5 shows intake of milk and milk products in women. These three
categories of intake (monthly, weekly and daily) correspond to the nine categories in
the FFQ as we consider the daily intake 1 - 6 times per day, the weekly intake 1– 6
times per week and monthly 1 - 3 times per month. About one fourth (26.3%) of the
women reported consuming milk daily, 29.8% weekly and 43.9% monthly. Nearly
one fifth (19.5%) of the women were consuming yogurt daily, while the majority
(61.8%) were consuming it weekly.
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Table 3.5: Milk and milk products intake in women
Variables
Milk
Monthly
Weekly
Daily
Yogurt
Monthly
Weekly
Daily
n: Frequency

n (%)
247 (43.9)
168 (29.8)
148 (26.3)
105 (18.7)
348 (61.8)
110 (19.5)

Table 3.6 shows the distribution of consumption of vegetables among women. A
high proportion of women reported eating fresh (68.2%) and leafy (46.5%)
vegetables daily. Below one fifth (19.3%) of the women reported eating cooked
vegetables daily, 47% weekly and 33% monthly. The least proportion of women
reported eating fried (4.2%) and boiled (1.1%) potatoes daily.
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Table 3.6: Vegetables intake in women
Variables
Fresh vegetables
Monthly
Weekly
Daily
Cooked vegetables
Monthly
Weekly
Daily
Leafy vegetables
Monthly
Weekly
Daily
Boiled potato
Monthly
Weekly
Daily
Fried potato
Monthly
Weekly
Daily
n: Frequency

n (%)
37 (6.5)
142 (25.2)
384 (68.2)
189 (33.5)
265 (47.0)
109 (19.3)
110 (19.5)
191 (35.0)
262 (46.5)
441 (78.3)
116 (20.6)
6 (1.1)
225 (39.9)
314 (55.7)
24 (4.2)

Table 3.7 shows the distribution of fruits and nuts intake in women. Overall,
the consumption of fruits per day among women was low. The most frequently
consumed fruit each day by women was dates (46.0%), followed by nuts (9.2%). The
least frequently consumed fruits each day by women were mango (4.4%) and grapes
(4.6%).
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Table 3.7: Fruits and Nuts intake in women
Variables
Banana
Monthly
Weekly
Daily
Grapes
Monthly
Weekly
Daily
Mango
Monthly
Weekly
Daily
Date
Monthly
Weekly
Daily
Nuts
Monthly
Weekly
Daily
n: Frequency

n (%)
188 (38.5)
263 (53.9)
37 (7.6)
339 (60.3)
197 (35.1)
26 (4.6)
404 (71.8)
134 (23.8)
25 (4.4)
146 (27.9)
158 (28.1)
259 (46.0)
283 (50.3)
228 (40.5)
52 (9.2)
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Table 3.8 shows the consumption pattern of meat in women. Chicken was
reported as the most frequently consumed meat by women (21.8%), followed by fish
(8.2%), while processed (1.0%) and red (2.1%) meats were consumed by the lowest
proportion of women.

Table 3.8: Meat intake in women
Variables
Fresh red meat
Monthly
Weekly
Daily
Processed meat
Monthly
Weekly
Daily
Chicken
Monthly
Weekly
Daily
Fish
Monthly
Weekly
Daily
n: Frequency

n (%)
189 (33.5)
362 (64.3)
12 (2.1)
490 (87.0)
67 (11.9)
6 (1.0)
29 (5.2)
411 (73.0)
123 (21.8)
83 (14.7)
434 (77.1)
46 (8.2)
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Table 3.9 presents the information on the intake of sweets and beverages in
women. A significant proportion of women reported eating sweets (34.8%) daily. In
beverages, the highest proportion of women reported drinking tea (62.2%) daily and
55.2% reported drinking fresh juice daily. A small proportion of women reported
consuming soft drink (13.9%) daily.

Table 3.9: Sweets and beverages intake in women
Variables
Sweets
Monthly
Weekly
Daily
Beverages
Soft drinks
Monthly
Weekly
Daily
Fresh juices
Monthly
Weekly
Daily
Tea
Monthly
Weekly
Daily
Coffee
Monthly
Weekly
Daily
n: Frequency

n (%)
91 (16.1)
276 (49.0)
196 (34.8)

345 (61.2)
140 (24.8)
78 (13.9)
50 (8.8)
202 (35.8)
311 (55.2)
103 (18.3)
110 (19.5)
350 (62.2)
226 (40.1)
145 (25.8)
192 (34.1)
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Table 3.10 shows the frequency of intake of cereals among women. The most
frequently consumed cereals each day by women were bread (88.9%) and rice
(83.8%). The least frequently consumed food each day by women were pizza (0.4%)
and pasta (3.2%).

Table 3.10: Cereals intake in women
Variables
Rice
Monthly
Weekly
Daily
Bread
Monthly
Weekly
Daily
Pasta
Monthly
Weekly
Daily
Pizza
Monthly
Weekly
Daily
n: Frequency

n (%)
9 (1.6)
82 (14.56)
472 (83.8)
3 (0.53)
59 (10.4)
501 (88.9)
83 (14.7)
462 (82.1)
18 (3.2)
353 (62.7)
208 (36.9)
2 (0.4)

3.6 Baseline Distribution of Vitamin D Status

The mean serum concentration of vitamin D in pregnant women was 12.7 ± 8.1
ng/ml, below three fifth (58.3%) of the women had a vitamin D deficiency and one
fourth (26.4%) had an insufficiency according to IOM criteria (See Table 3.11 and
Figure 3.8).
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Table 3.11: Baseline vitamin D status of women
Variables
n (%) / Mean ±SD
Vitamin D – ng/ml, Mean (±SD)
12.7 ±8.1
Vitamin D levels – IOM, n (%)
Normal (≥ 20 ng/ml)
86 (15.3)
Insufficiency (12 - 20 ng/ml)
148 (26.4)
Deficiency (< 12 ng/ml)
327 (58.3)
Vitamin D levels – IOM, n (%)
No deficiency (≥ 12 ng/ml)
234 (41.7)
Deficiency (< 12 ng/ml)
327 (58.3)
n: Frequency, SD: Standard Deviation, IOM: Institute of Medicine
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Vitamin D status according to IOM criteria

Figure 3.8: Baseline vitamin D insufficiency and deficiency in women
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3.7 Incidence of Gestational Diabetes

3.7.1 Overall Incidence of Gestational Diabetes

In pregnant women, the mean fasting OGTT was 4.6 ± 0.6 Mmol/L, postprandial OGTT was 5.8 ± 1.4 Mmol/L and fasting blood sugar was 4.7 ±0.43
Mmol/L. The overall incidence of GDM was 15.2% (95% CI: 12.4% - 18.5%) as per
WHO (2013) criteria (See Figure 3.9 and Table 3.12).

Table 3.12: Gestational Diabetes status of women
Variables
n (%) / Mean ±SD
Fasting OGTT – Mmol/L, Mean (±SD)
4.6 ± 0.61
Fasting Blood Sugar – Mmol/L, Mean (±SD)
4.7 ± 0.43
Post-prandial OGTT – Mmol/L, Mean (±SD)
5.8 ± 1.4
Incidence of Gestational Diabetes – WHO, n (%)
81(15.2)
n: Frequency, SD: Standard Deviation, OGTT: Oral Glucose Tolerance Test,
ADA: American Diabetes Association
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Incidence of Gestational Diabetes by WHO (2013) criteria
Figure 3.9: Overall incidence of Gestational Diabetes
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3.7.2

Incidence of Gestational
Characteristics

Diabetes

by

Baseline

Demographic

Table 3.13 shows the incidence of GDM by demographic characteristics of
women. Women with GDM (31.1 ± 5.4 years) were older (p = 0.008) than those
without GDM (29.3 ± 5.7 years). There were no significant differences in the
incidence of GDM by education level (p = 0.941), and type of occupation (p =
0.365). The incidence of GDM was slightly higher (p = 0.089) in women with
positive family history of diabetes (17.3%) as compared to women without family
history of diabetes (11.5%).

Table 3.13: Incidence of GDM by baseline demographic characteristics of women
Variables

All

GDM
(n=81)
31.1 ± 5.4

No GDM
(n=452)
29.3 ± 5.7

P Value

Age – Years, Mean ±SD
533
0.008
Education level, n (%)
Up to primary
22
4 (18.2)
18 (81.8)
0.941
Up to secondary
37
6 (16.2)
31 (83.8)
Up to high school
285
41 (14.4)
244 (85.6)
≥ College/University
189
30 (15.9)
159 (84.1)
Work Status, n (%)
Government employee
87
14 (16.1)
73 (83.9)
0.365
House wife
404
65 (16.1)
339 (83.9)
Other
42
2 (4.6)
40 (95.1)
Family history of Diabetes, n (%)
Positive
342
59 (17.3)
283 (82.7) 0.089
Negative
191
22 (11.5)
169 (88.5)
N: Frequency, SD: Standard Deviation
Chi-square and Fischer Exact tests were applied to compare proportions.
Unpaired t-tests were applied to compare means.
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3.7.3 Incidence of Gestational Diabetes by Baseline Clinical Characteristics

Table 3.14 shows the distribution and average differences in clinical
characteristics of women by GDM status. Average BMI before pregnancy (29.9 ± 8.0
vs 26.7 ± 6.3, p < 0.001) and fasting (5.5 ± 0.7 vs 4.5 ± 0.4, p < 0.001) and 2-hour
postprandial (7.9 ± 1.7 vs 5.5 ± 1.0, p < 0.001) OGTT were significantly higher in
women with GDM as compared to women without GDM. Likewise, average vitamin
D levels (12.3 ± 7.9 vs 12.8 ± 8.3, p < 0.001 were significantly lowers in GDM
women compared to those without GDM. The average systolic and diastolic blood
pressures were not significantly different between women with GDM and those
without GDM. The incidence of GDM was significantly (p = 0.002) different by
BMI categories i.e. 9.6% in women with normal BMI, 15.7% in overweight women
and 22.6% in obese women (See Figure 3.10).
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Table 3.14: Incidence of Gestational Diabetes by baseline clinical characteristics of
women
Variables
Anthropometric indices
Body Mass Index before pregnancy –
kg/m2, Mean ±SD
Body Mass Index – Cat, n (%)
Normal (< 25.0 kg/m2)
Overweight (25.0-29.9 kg/m2)
Obese (≥30 kg/m2)
Body Mass Index during pregnancy –
kg/m2, Mean ±SD
Blood Pressure – mmHg
Systolic Blood Pressure, Mean ±SD
Diastolic Blood Pressure, Mean ±SD
High blood pressure, n (%)

GDM
(n=81)

No GDM
(n=452)

P Value

29.9 ±8.0

26.7 ±6.3

<0.001

22 (9.6)
22 (15.7)
37 (22.6)
30.4 ±7.8

207 (90.4)
118 (84.3)
127 (77.4)
27.4 ±6.4

0.002

108.9 ±11.5
67.7 ±9.2
79 (97.5)

107.5 ±11.8
65.3 ±18.5
445 (98.5)

0.989
0.854
0.632

<0.001

Biochemical parameters
Fasting OGTT – Mmol/L, Mean ±SD 5.5 ±0.7
4.5 ±0.4
<0.001
Post-prandial OGTT – Mmol/L,
7.9 ±1.7
5.5 ±1.0
<0.001
Mean ±SD
Fasting Blood Sugar – Mmol/L,
4.9 ±0.4
4.7 ±0.4
<0.001
Mean ±SD
Vitamin D – ng/ml, Mean ±SD
12.3±7.9
12.8 ±8.3
<0.001
n: Frequency, SD: Standard Deviation, OGTT: Oral Glucose Tolerance Test
Chi-square tests were applied to compare proportions. Unpaired tests were
applied to compare means.

59

25

22.6

Percent (%)

20
15.7
15
10

9.6

5
0
Normal

Overweight

Obese

Incidence of GDM
Figure 3.10: Incidence of GDM by baseline Body Mass Index categories

3.7.4 Incidence of Gestational Diabetes by Baseline Physical Activity Levels

Table 3.15 shows the comparison of physical activity levels in women with and
without GDM. The three categories of the physical activity correspond to the GPAQ
questionnaire as we used the GPAQ Analysis Guide (For further information:
www.who.int/chp/steps).

The median (iqr) METs per week (870 [1280] vs 840 [1320], p = 0.447) and
sitting time per day (300 [180] vs 240 [180], p = 0.628) were not significantly
different in women with GDM versus those with no GDM. The incidence of GDM
was not significantly (p = 0.329) different between women with low (11.4%) versus
adequate (15.1%) METs weekly. Likewise, the incidence of GDM was similar (p =
0.821) among women who performed high (16.7%), moderate (14.2%) and low
(16.0%) physical activity in early pregnancy (See Figure 3.11). Similarly, the
incidence of GDM was insignificantly lower in pregnant women who performed
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travel (12.7% vs 17.8%, p = 0.101) and recreational (13.5% vs 17.1%, p = 0.247)
moderate and physical activities per day than those women who did not perform
these activities.

Table 3.15: Incidence of Gestational Diabetes by baseline physical activity levels of
women

Variables

All

GDM
(n=81)
n (%)
870 (1280)

No GDM
(n=452)
n (%)
840 (1320)

P Value

Total METs per week, Median (iqr) 533
0.447
METs, n (%)
0.329
<600 per week (Low)
123
14 (11.4)
109 (88.6)
≥600 per week (Adequate)
238
36 (15.1)
202 (84.9)
Physical activity levels – WHO
0.821
criteria, n (%)
High
42
7 (16.7)
35 (83.3)
Moderate
282
40 (14.2)
242 (85.8)
Low
147
30 (16.0)
157 (84.0)
Work related moderate and vigorous
0.740
physical activity per day, n (%)
Yes
35
6 (17.1)
29 (82.9)
No
498
75 (15.1)
423 (84.9)
Travel related physical activity per
0.101
day, n (%)
Yes
275
35 (12.7)
240 (87.3)
No
258
46 (17.8)
212 (12.2)
Recreational moderate and vigorous
0.247
physical activity per day, n (%)
Yes
275
37 (13.5)
238 (86.5)
No
258
44 (17.1)
214 (82.9)
Sedentary time per day – minutes,
526
300 (180)
240 (180)
0.628
Median (iqr)
n: Frequency, METs: Metabolic Equivalent, iqr: Interquartile Range
Chi-square tests were applied to compare proportions. Wilcoxon Rank Sum tests
were applied to compare medians.
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Figure 3.11: Incidence of GDM by baseline levels of physical activity of women

3.7.5 Incidence of Gestational Diabetes by Supplements and Dietary Intake

The incidence of GDM was similar in women who used multivitamin (15.1% vs
15.2%, p = 0.620) and vitamin D supplements (12.3% vs 15.9%, p = 0.347) versus
those who did not use these supplements (See Table 3.16 for details).

Table 3.16: Incidence of Gestational Diabetes by supplements intake in women
during the last six months

Variables

All

GDM
(n=81)
n (%)

No GDM
(n=452)
n (%)

Multivitamins /minerals supplements
use during the last six months
Yes
99
15 (15.1)
84 (84.9)
No
434
66 (15.2)
368 (84.3)
Vitamin D supplements use during
the last six months
Yes
106
13 (12.3)
93 (87.7)
No
427
68 (15.9)
359 (84.1)
n: Frequency
Chi-square and Fischer Exact tests were applied to compare proportions.

P Value
0.620

0.347
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Table 3.17 shows the incidence of GDM by the consumption of milk and
milk products. No differences in the incidence of GDM were observed by the
frequency of consumption of milk (p = 0.759) and yogurt (p = 0.348).

Table 3.17: Incidence of Gestational Diabetes by milk and milk products intake in
women

Variables

All

GDM
(n=81)
n (%)

No GDM
(n=452)
n (%)

P Value

Milk
0.759
Monthly
241
34 (14.1)
207 (85.9)
Weekly
148
25 (16.9)
123 (83.1)
Daily
144
22 (15.3)
122 (84.7)
Yogurt
0.348
Monthly
102
20 (19.6)
82 (80.4)
Weekly
329
48 (14.6)
281 (85.4)
Daily
102
13 (12.7)
89 (87.3)
n: Frequency
Chi-square and Fischer Exact tests were applied to compare proportions

Table 3.18 shows the incidence of GDM by the consumption of vegetable
among pregnant women. The incidence of GDM was different (p = 0.056) among
women who ate cooked vegetables daily (20.0%), weekly (16.8%) and monthly
(10.3%). No significant differences were observed in the incidence of GDM by the
frequency of intake of fresh vegetables (p = 0.493), leafy vegetables (p = 0.320),
fried potato (p = 0.698) and boiled potato (p = 0.923).
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Table 3.18: Incidence of Gestational Diabetes by vegetable intake in women

Variables

All

GDM
(n=81)
n (%)

No GDM
(n=452)
n (%)

Fresh vegetables
Monthly
36
3 (8.3)
33 (91.7)
Weekly
135
21 (15.6)
114 (84.4)
Daily
362
57 (15.7)
305 (84.3)
Cooked vegetables
Monthly
184
19 (10.3)
165 (89.7)
Weekly
244
41 (16.8)
203 (83.2)
Daily
105
21 (20.0)
84 (80.0)
Leafy vegetables
Monthly
105
13 (12.4)
92 (87.6)
Weekly
179
24 (13.4)
155 (86.6)
Daily
249
44 (17.7)
205 (82.3)
Boiled potato
Monthly
417
62 (14.9)
355 (85.1)
Weekly
110
18 (16.4)
92 (83.6)
Daily
6
1 (16.7)
5 (83.3)
Fried potato
Monthly
213
32 (15.1)
181 (85.0)
Weekly
298
47 (15.0)
251 (84.2)
Daily
22
2 (9.1)
20 (90.9)
n: Frequency
Chi-square and Fischer Exact tests were applied to compare proportions

P Value
0.493

0.056

0.320

0.923

0.698

Table 3.19 shows the incidence of GDM by the consumption of fruits and
nuts among pregnant women. The incidence of GDM significantly different by
frequency of intake of dates in early pregnancy among women (p = 0.035). As such,
it was the highest among women who ate dates daily (18.2%), followed by those who
ate dates weekly (16.4%), while it was the lowest at 8.6% among those who ate dates
monthly. No significant differences were observed in the incidence of GDM by the
frequency of intake of banana (p = 0.642), grapes (p = 0.619), mango (p = 0.471) and
nuts (p = 0.158).
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Table 3.19: Incidence of Gestational Diabetes by fruits and Nuts intake in women

Variables

All

GDM
(n=81)
n (%)

No GDM
(n=452)
n (%)

Banana
Monthly
179
28 (15.6)
151 (84.4)
Weekly
246
34 (13.8)
212 (86.2)
Daily
36
7 (19.4)
29 (80.6)
Grapes
Monthly
320
45 (14.1)
275 (85.9)
Weekly
186
31 (16.7)
155 (83.3)
Daily
26
5 (19.2)
21 (80.8)
Mango
Monthly
385
63 (16.4)
322 (83.6)
Weekly
126
15 (11.9)
111 (88.1)
Daily
22
3 (13.6)
19 (86.4)
Dates
Monthly
140
12 (8.6)
128 (91.4)
Weekly
277
24 (16.4)
122 (84.6)
Daily
77
45 (18.2)
202 (81.8)
Nuts
Monthly
272
35 (12.9)
237 (87.1)
Weekly
212
40 (18.9)
172 (83.1)
Daily
49
6 (12.2)
43 (87.8)
n: Frequency
Chi-square and Fischer Exact tests were applied to compare proportions

P Value

0.642

0.619

0.471

0.035

0.158

Table 3.20 shows the incidence of GDM by the consumption of meat among
pregnant women. No significant differences were observed in the incidence of GDM
by the frequency of intake of red meat (p = 0.053), processed meat (p = 0.788),
chicken (p = 0.108) and fish (p = 0.188).
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Table 3.20: Incidence of Gestational Diabetes by meat intake in women

Variables

All

GDM
(n=81)
n (%)

No GDM
(n=452)
n (%)

Fresh red meat
Monthly
179
20 (11.2)
159 (88.8)
Weekly
342
57 (17.2)
285 (82.8)
Daily
12
4 (33.3)
8 (67.7)
Processed meat
Monthly
469
72 (15.3)
397 (84.7)
Weekly/Daily
64
9 (14.1)
55 (85.9)
Chicken
Monthly
28
3 (10.7)
25 (89.3)
Weekly
390
67 (17.2)
323 (82.8)
Daily
115
11 (9.6)
104 (90.4)
Fish
Monthly
81
7 (8.6)
74 (91.4)
Weekly
410
68 (16.6)
342 (83.4)
Daily
42
6 (14.3)
36 (85.7)
n: Frequency
Chi-square and Fischer Exact tests were applied to compare proportions

P Value
0.053

0.788

0.108

0.188

Table 3.21 shows the incidence of GDM by the intake of sweets and beverages.
No differences in the incidence of GDM were noted with the consumption pattern of
sweets (p = 0.410), soft drinks (p = 0.456), fresh juices (p = 0.690), tea (p = 0.567)
and coffee (p = 0.530).
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Table 3.21: Incidence of Gestational Diabetes by sweets and beverages intake in
women
GDM (n=81)
Variables
Sweets
Sweets
Monthly
Weekly
Daily

n (%)

No GDM
(n=452)
n (%)

17 (19.8)
36 (13.9)
28 (15.0)

69 (80.2)
224 (86.1)
159 (85.0)

All

86
260
187

P Value

0.410

Beverages
Soft drinks
Monthly
329
55 (16.7)
274 (83.3)
0.456
Weekly
130
17 (13.1)
113 (86.9)
Daily
74
9 (12.2)
65 (87.8)
Fresh juices
Monthly
48
9 (18.7)
39 (81.3)
0.690
Weekly
194
27 (13.9)
167 (86.1)
Daily
291
45 (15.5)
246 (84.5)
Tea
Monthly
94
11 (18.4)
83 (88.3)
0.567
Weekly
105
16 (19.7)
89 (84.7)
Daily
334
54 (61.9)
280 (83.8)
Coffee
Monthly
213
34 (16.0)
179 (84.0)
0.530
Weekly
134
23 (17.2)
111 (82.8)
Daily
186
24 (12.9)
162 (87.1)
n: Frequency
Chi-square and Fischer Exact tests were applied to compare proportions

Table 3.22 shows the incidence of GDM by the consumption pattern of cereals.
The incidence of GDM was not significantly different in women who ate rice (p =
0.273), bread (p = 0.720), pasta (p = 0.204) and pizza (p = 0.789) daily, weekly and
monthly.
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Table 3.22: Incidence of Gestational Diabetes by intake of cereals in women

Variables

All

GDM
(n=81)
n (%)

No GDM
(n=452)
n (%)

Rice
Monthly/Weekly
88
10 (11.4)
78 (88.6)
Daily
445
71 (16.0)
374 (84.0)
Bread
Monthly/Weekly
61
8 (11.0)
53 (86.9)
Daily
472
73 (15.5)
399 (84.5)
Pasta
Monthly
80
12 (15.0)
68 (85.0)
Weekly
436
69 (15.8)
367 (84.2)
Daily
17
0 (0.0)
17 (100.0)
Pizza
Monthly
332
52 (15.7)
280 (85.6)
Weekly/Daily
201
29 (14.4)
172 (35.8)
n: Frequency
Chi-square and Fischer Exact tests were applied to compare proportions

P Value
0.273

0.720

0.204

0.789

3.8 Association between Gestational Diabetes and Vitamin D

The average vitamin D concentration and distribution of vitamin D status
according to GDM status are given in Table 3.23 and Figure 3.12.
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Table 3.23: Incidence of Gestational Diabetes by baseline Vitamin D status in
women
Variables

GDM
(n=81)
12.3±7.9

All

No GDM
(n=452)
12.8 ±8.3

P Value

Percent (%)

Vitamin D – ng/ml, Mean ±SD
533
<0.001
Vitamin D levels – IOM, n (%)
Normal (≥ 20 ng/ml)
84
9 (10.7)
75 (89.3)
0.473
Insufficiency (12 - 20 ng/ml)
137
22 (16.1)
115 (83.9)
Deficiency (< 12 ng/ml)
312
50 (16.0)
262 (84.0)
Vitamin D levels – IOM, n (%)
No deficiency (≥ 12 ng/ml)
221
31 (14.0)
190 (86.0) 0.527
Deficiency (< 12 ng/ml)
312
50 (16.0)
262 (84.0)
n: Frequency, SD: Standard Deviation
Chi-square tests were applied to compare proportions. Unpaired tests were
applied to compare means.
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Figure 3.12: Incidence of Gestational Diabetes in women by baseline Vitamin D
Status

Table 3.24 shows the results of fitting a binary logistic regression taking vitamin D
status either as a continuous variable, an ordinal variable with three categories i.e.
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normal, vitamin D insufficiency and vitamin D insufficiency or a binary variable
with two categories i.e. vitamin D deficiency versus no deficiency. Using vitamin D
as a continuous covariate, there was no statistically significant association with GDM
(OR: 0.99, 95% CI: 0.96 – 1.02, p = 0.574). When vitamin D was used as an ordinal
covariate, no association was found between vitamin D deficiency and GDM (OR:
1.59, 95% CI: 0.75 – 3.38, p = 0.228) and vitamin D insufficiency and GDM (OR:
1.59, 95% CI: 0.69 – 3.65, p = 0.270) as compared to women with normal vitamin D.
Similarly, there was no association between vitamin D deficiency and GDM (OR:
1.17, 95%CI: 0.72 – 1.90, p = 0.527).

Table 3.24: Unadjusted logistic regression of Gestational Diabetes with Vitamin D
status in women
Variables

GDM (n=81)
OR
SE
0.99
0.01

95% CI
0.96 – 1.02

Vitamin D – ng/ml – continuous
Vitamin D levels – IOM
Normal
1
Insufficiency
1.59
0.67 0.69 – 3.65
Deficiency
1.59
0.61 0.75 – 3.38
Vitamin D levels – IOM
No deficiency
1
Deficiency
1.17
0.29 0.72 – 1.90
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval

P Value
0.574

0.270
0.228

0.527

Table 3.25 shows multiple logistic regression analysis of GDM with vitamin D
status that was adjusted for age, family history of diabetes, levels of physical activity,
BMI before pregnancy, red meat intake, cooked vegetables intake and dates intake.
Like unadjusted analysis, vitamin D concentration was not associated with odds of
GDM (AOR: 0.99, 95% CI: 0.95 – 1.02, p = 0.450). Likewise, the odds of GDM
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were not significantly different in women with vitamin D insufficiency (AOR: 2.11,
95% CI: 0.81 – 5.64, p = 0.101) and deficiency (AOR: 1.94, 95% CI: 0.88 – 5.32,
p = 0.118) as compared to women with normal vitamin D status. Also, the odds of
GDM were not significantly (AOR: 1.18, 95% CI: 0.70 – 1.99, p = 0.537) higher in
vitamin D deficient women as compared to non-deficient women.

Table 3.25 Adjusted logistic regression of Gestational Diabetes with Vitamin D
status in women
Variables

GDM (n=81)
AOR
SE
0.99
0.02

95% CI
0.95 – 1.02

P Value
0.450

Vitamin D – ng/ml – continuous
Vitamin D levels – IOM
Normal
1
Insufficiency
2.11
1.05 0.81 – 5.64 0.101
Deficiency
1.94
0.99 0.88 – 5.32 0.118
Vitamin D levels – IOM
No deficiency
1
Deficiency
1.18
0.62 0.70 – 1.99 0.537
AOR: Adjusted Odds Ratio, SE: Standard Error, CI: Confidence Interval
The model was adjusted for age, family history of diabetes, levels of physical
activity, BMI before pregnancy, red meat intake, cooked vegetables intake and
dates intake

3.9 Association between Gestational Diabetes and Physical Activity

Table 3.26 shows unadjusted logistic regression analysis of GDM with physical
activity levels of pregnant women. The odds of GDM were not significantly different
(OR: 0.72, 95% CI: 0.37 – 1.39, p = 0.331) between women who had adequate METs
per day versus low METs per day. Similarly, compared to women who reported high
levels of physical activity, the odds of GDM were not significantly different in
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women who reported low (OR: 1.04, 95% CI: 0.43 – 2.58, p = 0.257) and moderate
(OR: 0.87, 95% CI: 0.52 – 1.45, p = 0.582) levels of physical activity.

Table 3.26: Unadjusted logistic regression of Gestational Diabetes with physical
activity in women
Variables

GDM (n=81)
OR
SE
95% CI

P Value

METs, n (%)
< 600 per week
1
≥ 600 per week
0.72
0.24 0.37 – 1.39 0.331
Physical activity levels per day
High
1
Moderate
0.87
0.23 0.52 – 1.45 0.582
Low
1.04
0.48 0.43 – 2.58 0.257
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval, METs: Metabolic
Equivalents

Table 3.27 shows multiple logistic regression analysis of GDM with physical
activity that was adjusted for vitamin D status, age, family history of diabetes, BMI
before pregnancy and intake of red meat, cooked vegetables and dates. The odds of
GDM were not significantly different by METs status (AOR: 0.92, 95% CI: 0.50 –
1.67, p = 0.778) and moderate (AOR: 0.78, 95% CI: 0.45 – 1.34, p = 0.372) and low
(AOR: 1.09, 95% CI: 0.43 – 2.79, p = 0.850) physical activity levels.
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Table 3.27: Adjusted logistic regression of Gestational Diabetes with physical
activity during the last week in women
Variables

GDM (n=81)
OR
SE
95% CI

P Value

METs, n (%)
< 600 per week
1
≥ 600 per week
0.92
0.24 0.50 – 1.67 0.778
Physical activity levels per day
High
1
Moderate
0.78
0.23 0.45 – 1.34 0.372
Low
1.09
0.48 0.43 – 2.79 0.850
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval, METs: Metabolic
Equivalents
The model was adjusted for vitamin D status, age, family history of diabetes, BMI
before pregnancy and red meat, cooked vegetables and dates intake

3.10 Association between Gestational Diabetes and Diet

Table 3.28 shows simple logistic regression analysis of GDM with use of
supplements. The consumption of multivitamins / minerals (OR: 1.00, 95% CI: 0.54
– 1.83, p = 0.989) and vitamin D supplements (OR: 0.74, 95% CI: 0.39 – 1.39, p =
0.349) was not significantly associated with GDM.

Table 3.28: Simple logistic regression of Gestational Diabetes with use of
supplements during the last six months in women
Variable
Multivitamins /minerals supplements
use during the last six months
No
Yes
Vitamin D supplements use during the
last six months
No
Yes

GDM (n=81)
OR
SE

95% CI

P value

1
1.00

0.31

0.54 – 1.83

0.989

1
0.74

0.24

0.39 – 1.39

0.349

OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval
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Table 3.29 shows simple logistic regression analysis of GDM with intake of
milk and yogurt in women. The odds of GDM were not significantly different with
respect to frequency of consumption of milk and yogurt.

Table 3.29: Simple logistic regression of Gestational Diabetes with intake of milk
and milk products in women
Variable

GDM (n=81)
OR
SE

95% CI

Milk
Monthly
1
Weekly
1.24
0.35
0.71 – 2.17
Daily
1.09
0.33
0.61 – 1.96
Yogurt
Monthly
1
Weekly
0.70
0.21
0.39 – 1.25
Daily
0.60
0.23
0.28 – 1.28
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval

P value

0.458
0.753

0.226
0.186

Table 3.30 shows logistic regression analysis of GDM with intake of vegetables
in pregnant women. The odds of GDM were significantly higher in women who ate
cooked vegetables weekly (OR: 1.75, 95% CI: 0.98 – 3.13, p = 0.058) and daily (OR:
2.17, 95% CI: 1.11 – 4.26, p = 0.024) as compared to those women who ate cooked
vegetables monthly. The consumption pattern of fresh vegetables, leafy vegetables,
boiled potato and fried potato were not associated with GDM.
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Table 3.30: Simple logistic regression of Gestational Diabetes with intake of
vegetables in women
Variable

GDM (n=81)
OR
SE

95% CI

Fresh vegetables
Monthly
1
Weekly
2.02
1.31
0.57 – 7.21
Daily
2.06
1.27
0.61 – 6.93
Cooked vegetables
Monthly
1
Weekly
1.75
0.52
0.98 – 3.13
Daily
2.17
0.75
1.11 – 4.26
Leafy vegetables
Monthly
1
Weekly
1.10
0.40
0.53 – 2.26
Daily
1.52
0.51
0.78 – 2.95
Boiled potato
Monthly
1
Weekly
1.12
0.33
0.63 – 1.99
Daily
1.14
1.26
0.13 – 9.96
Fried potato
Monthly
1
Weekly
1.06
0.26
0.65 – 1.72
Daily
0.57
0.43
0.13 – 2.54
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval

P value

0.276
0.245

0.058
0.024

0.804
0.218

0.698
0.902

0.818
0.457

Table 3.31 shows simple logistic regression analysis of GDM with intake of
fruits and nuts in women. Compared to women who ate dates monthly, those women
who ate dates weekly (OR: 2.10, 95% CI: 1.06 – 4.38, p = 0.048) and daily (OR:
2.38, 95% CI: 1.21 – 4.66, p = 0.012) were significantly more likely to develop
GDM, while GDM was not significantly associated with intake pattern of banana,
grapes, mango and nuts.
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Table 3.31: Simple logistic regression of Gestational Diabetes with intake of fruits
and nuts in women
Variable

GDM (n=81)
OR
SE

95% CI

Banana
Monthly
1
Weekly
0.86
0.24
0.50 – 1.49
Daily
1.37
0.61
0.52 – 3.26
Grapes
Monthly
1
Weekly
1.22
0.31
0.74 – 2.01
Daily
1.45
0.76
0.52 – 4.05
Mango
Monthly
1
Weekly
0.69
0.21
37.8 – 1.26
Daily
0.81
0.51
21.2 – 2.81
Dates
Monthly
1
Weekly
2.10
0.76
1.06 – 4.38
Daily
2.38
1.00
1.21 – 4.66
Nuts
Monthly
1
Weekly
1.57
0.39
0.96 – 2.58
Daily
0.94
0.44
0.37 – 2.38
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval

P value

0.600
0.574

0.430
0.473

0.229
0.736

0.048
0.012

0.072
0.904

Table 3.32 shows simple logistic regression analysis of GDM with intake of
meat. Daily consumption red meat (OR: 3.97, 95% CI: 1.10 – 14.40, p = 0.036) was
positively associated with GDM. The consumption of processed meat, chicken and
fish was not associated with GDM.
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Table 3.32: Simple logistic regression of Gestational Diabetes with intake of meat in
women.
Variable

GDM (n=81)
OR
SE

95% CI

Fresh red meat
Monthly
1
Weekly
1.59
0.44
0.92 – 2.74
Daily
3.97
2.61
1.10 – 14.40
Processed meat
Monthly
1
Weekly
0.88
0.35
0.40 – 1.94
Daily
1.10
1.21
0.13 – 9.58
Chicken
Monthly
1
Weekly
1.73
1.08
0.51 – 5.89
Daily
0.88
0.61
0.23 – 3.39
Fish
Monthly
1
Weekly
2.10
0.86
0.93 – 4.76
Daily
1.76
1.04
0.55 – 5.62
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval

P value

0.098
0.036

0.755
0.929

0.382
0.855

0.075
0.339

Table 3.33 shows simple logistic regression analysis of GDM with intake of
sweets and beverages. Gestational diabetes was not associated with consumption of
sweets, soft drinks, fresh juices, tea and coffee.
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Table 3.33: Simple logistic regression of Gestational Diabetes with intake of sweets
and beverages
Variable

GDM (n=81)
OR
SE

95% CI

Sweets
Sweets
Monthly
1
Weekly
0.65
0.21
0.34 – 1.23
Daily
0.71
0.24
0.37 – 1.39
Beverages
Soft drinks
Monthly
1
Weekly
0.75
0.22
0.42 – 1.35
Daily
0.69
0.26
0.32 – 1.45
Fresh juices
Monthly
1
Weekly
0.70
0.30
0.31 – 1.61
Daily
0.79
0.32
0.36 – 1.75
Tea
Monthly
1
Weekly
1.35
0.57
0.59 – 3.09
Daily
1.45
0.51
0.73 – 2.91
Coffee
Monthly
1
Weekly
1.09
0.32
0.61 – 1.95
Daily
0.78
0.22
0.44 – 1.37
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval

P value

0.189
0.323

0.335
0.335

0.401
0.565

0.468
2.91

0.769
0.388

Table 3.34 shows simple logistic regression analysis of GDM with intake of
cereals. Gestational diabetes was not associated with consumption of rice, bread,
pasta and pizza.
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Table 3.34: Simple logistic regression of Gestational Diabetes with supplements and
diet intake
Variable

GDM (n=81)
OR
SE

95% CI

Rice
Monthly
1
Weekly
0.39
0.35
0.07 – 2.23
Daily
0.66
0.54
0.13 – 3.26
Bread
Monthly/Weekly
1
Daily
1.21
0.48
0.55 – 2.65
Pasta
Monthly
1
Weekly
1.06
0.36
0.55 – 2.07
Pizza
Monthly
1
Weekly
0.92
0.23
0.56 – 1.50
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval

P value

0.293
0.615

0.631

0.852

0.735

Table 3.35 shows multiple logistic regression analysis of GDM with diet intake
that was adjusted for vitamin D status, age, family history of diabetes and BMI
before pregnancy. Daily consumption of dates (AOR: 1.86, 95% CI: 1.03 – 6.49, p =
0.043) and red meat (AOR: 6.16, 95% CI: 1.31 – 28.92, p = 0.021) remained
significantly associated with the development of GDM. However, weekly (AOR:
1.83, 95% CI: 0.91 – 3.69, p = 0.087) and daily (AOR: 2.15, 95% CI: 0.93 – 4.95, p
= 0.072) consumption of cooked vegetables was not significantly associated with the
development of GDM.
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Table 3.35: Multiple logistic regression analysis of Gestational Diabetes with diet
intake in women
Variables

GDM (n=81)
AOR

SE

95% CI

P Value

Dates
Monthly
1
Weekly
1.64
0.60
0.69 – 3.35
0.224
Daily
1.86
1.21
1.03 – 6.49
0.043
Red meat
Monthly
1
Weekly
1.29
0.42
0.68 – 2.43
0.433
Daily
6.16
4.18
1.31 – 28.92
0.021
Cooked vegetables
Monthly
1
Weekly
1.83
0.65
0.91 – 3.69
0.087
Daily
2.15
0.91
0.93 – 4.95
0.072
AOR: Adjusted Odds Ratio, SE: Standard Error, CI: Confidence Interval
The model was adjusted for vitamin D status, age, family history of diabetes and
BMI before pregnancy

3.11 Association of Gestational Diabetes with Other Risk Factors

Table 3.36 shows simple logistic regression analysis of GDM with demographic
characteristics of women. Average increase in age by one year elevated the odds of
GDM by 6.0% (95% CI: 1.01 – 1.11, p = 0.008). Women with positive family
history of diabetes (OR: 1.60, 95% CI: 0.95 – 2.71, p = 0.079) were insignificantly
more likely to develop GDM as compared to women without family history of
diabetes. No association was observed between education level, type of occupation
and GDM.
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Table 3.36: Simple logistic regression analysis of gestational diabetes with
demographic characteristics
Variables

GDM
OR
1.06

SE
0.02

95% CI
1.01 – 1.11

P Value
0.008

Age – Years
Education level
Up to primary
1
Up to secondary
0.87
0.62
0.22 – 3.50
0.846
Up to high school
0.76
0.44
0.24 – 2.35
0.629
≥ College/University
0.85
0.50
0.27 – 2.68
0.781
Work Status
Government employee
1
House wife
0.99
0.32
0.53 – 1.88
0.999
self-employed/Student/Non0.26
0.20
0.06 – 1.20
0.085
government employee
Family history of Diabetes
Yes
1
No
1.60
0.43
0.95 – 2.71
0.079
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval, AED: Arab
Emirates Dirham

Table 3.37 shows simple logistic regression analysis of GDM with clinical
characteristics of women. Average increase in BMI by one kg/m2 increased the odds
of GDM by 7% (95% CI: 1.03 – 1.10, p < 0.001). Overweight (OR: 1.75, 95% CI:
0.93 – 3.30, p = 0.082) and obese (OR: 2.74, 95% CI: 1.55 – 4.86, p = 0.001) women
with high BMI were more likely to develop GDM as compared to women with
normal BMI. No association was noted between high blood pressure (OR: 1.61, 95%
CI: 0.33 – 7.89, p = 0.557) and GDM.
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Table 3.37: Simple logistic regression of Gestational Diabetes with Body Mass Index
Variables

GDM (n=81)
OR
SE
1.07
0.02

95% CI
1.03 – 1.10

Body Mass Index before pregnancy –
kg/m2
Body Mass Index categories before
pregnancy
Normal (< 25.0 kg/m2)
1
2
Overweight (25.0 - 29.9 kg/m )
1.75
0.57 0.93 – 3.30
2
Obese (≥ 30 kg/m )
2.74
0.80 1.55 – 4.86
OR: Odds Ratio, SE: Standard Error, CI: Confidence Interval

P Value
<0.001

0.082
0.001

Table 3.38 shows multiple logistic regression analysis of GDM with clinical
characteristics that was adjusted for vitamin D status, physical activity and diet
intake (dates, cooked vegetables, red meat) of women. The adjusted analysis shows
that positive family history of diabetes (AOR: 1.93, 95% CI: 1.02 – 3.62, p = 0.043)
and BMI before pregnancy (AOR: 1.07, 95% CI: 1.02 – 1.11, p = 0.003) were
significant risk factors of GDM.

Table 3.38: Adjusted logistic regression analysis of Gestational Diabetes with risk
factors

Variables

GDM (n=81)
AOR
SE
1.02
0.02

95% CI
0.97 – 1.07

P Value
0.520

Age – years
Family history of diabetes
No
1
Yes
1.93
0.62
1.02 – 3.62
0.043
Body Mass Index before
1.07
0.02
1.02 – 1.11
0.003
2
pregnancy – kg/m
AOR: Adjusted Odds Ratio, SE: Standard Error, CI: Confidence Interval
The model was adjusted for vitamin D status, levels of physical activity and diet
intake of women.

82

Chapter 4: Discussion
4.1 Summary of Results

The overall incidence of GDM was 15.2% (95% CI: 12.4% - 18.5%) according
to the WHO (2013) criteria. The incidence of GDM was 16.1% in vitamin D
insufficient women, 16.0% in vitamin D deficient women and 10.7% in women with
normal vitamin D. The prevalence of vitamin D deficiency and insufficiency was
58.3% and 26.4% respectively as per IOM criteria. Below one-tenth (8.5%) of
pregnant women reported high levels of physical activity. The median METs (iqr)
per week were 840 (1320) and median sedentary time per day was 240 (280)
minutes. The most frequently consumed foods were bread (88.9%), rice (83.8%),
fresh vegetables (68.2%), tea (62.2%), fresh juices (55.2%), leafy vegetables (46.5%)
and dates (46.0%).
This study found that vitamin D insufficiency and deficiency and physical
activity were not significantly associated with GDM. The positive family history of
diabetes, BMI and daily consumption of dates and red meat significantly increased
the likelihood of developing GDM in Emirati women.

4.2 Prevalence of Vitamin D Deficiency

The present study demonstrated a high prevalence of vitamin D insufficiency
(26.4%) and deficiency (58.3%) in pregnant Emirati women according to IOM
criteria. In addition to well-known factors such as low sunlight exposure and vitamin
D diet (Dawodu et al., 2003), the high prevalence of vitamin D deficiency could be
due to low consumption rate of vitamin D supplements among our sample. Since the
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present study did not investigate reasons for low supplement use, further research is
suggested in this area.

The prevalence of vitamin D deficiency estimated by our study (58.3%) is lower
than its prevalence of 69% in pregnant women reported by two studies from the UAE
(Hussein et al., 2016; Narchi et al., 2010). These estimates indicate that vitamin D
deficiency remains a wide-spread problem in pregnant women in the UAE despite
country-wide dairy food and oil fortification and supplementation of vitamin D
(Laleye et al., 2011). Therefore, more population-wide and multi-sectoral
interventions are needed to address this problem in the country.

The prevalence of vitamin D deficiency in pregnant women was slightly higher
than Saudi women (50%), according to a study (Al-Faris et al., 2016). Whereas,
another large study found a higher prevalence (86%) of vitamin D deficiency than us
(Al-Shaikh et al., 2016). In addition, studies from Qatar and Iran reported the
prevalence rate of vitamin D deficiency between 48 and 70% in pregnant women
respectively (Bener et al., 2013; Maghbooli et al., 2008). In addition to observational
studies, a recent review have concluded that prevalence of vitamin D in pregnant
women of Middle East countries ranges between 50 and 65% respectively (Karras et
al., 2016). Despite similar diet and life style practices, ethnicity and abundant light in
the Middle East countries, variations in the prevalence of vitamin D deficiency
among these studies could be due to differences in measurement methods and
diagnostic cut-offs for vitamin D deficiency. Even in the presence of these
limitations, these data indicate that vitamin D deficiency is a serious problem in
pregnant women in the Middle East region, which has also been demonstrated by
other studies (Eggemoen et al., 2016; Al-Mohaimeed et al., 2012).
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4.3 Incidence of Gestational Diabetes

Our study found that 15.2% (95% CI: 12.4% - 18.5%) of Emirati women
developed GDM as per WHO (2013) criteria in late pregnancy. To date, limited data
are available on the burden of GDM in the UAE. Nevertheless, two hospital based
follow-up studies conducted in Al Ain showed that GDM, as per ADA criteria, was
present in 12.9 and 14.2% of Emirati and South Asian women (Agarwal et al., 2010;
Agarwal et al., 2007). The burden of GDM shown by earlier studies is similar to our
results and shows that GDM is a common condition among Emirati women and
needs to be addressed urgently.

The magnitude of burden of GDM largely depends upon its diagnostic criteria,
which has been demonstrated by Agarwal and colleagues in their studies (Agarwal et
al., 2005; Agarwal et al., 2007). For instance, in one of their studies, the prevalence
of GDM according to ADA criteria was similar (14.2%) to our study, while it
increased up to 37% by using other criteria (Agarwal et al., 2007). This necessitates
the need for a unified criterion for diagnosing GDM in the UAE and elsewhere so
that trends of GDM can be monitored and compared within and across countries.

The incidence of GDM estimated by our study (15.2%) is higher than its global
incidence of 1 - 14% WHO (2013), indicating the seriousness of this problem in the
country. However, the prevalence of GDM in our study is lower than Saudi Arabia
and Qatar. For instance, the prevalence of GDM was 36.6% in Saudi women
according to a population based survey (Al-Rubeaan et al., 2014), while 24% of
Saudi women were classified having GDM in a recent cohort study (Serehi et al.,
2015). In Qatar, GDM was present in 16.3% of pregnant women (Bener et al., 2011).
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On the other hand, the incidence of GDM was lower in Bahrain (12.5%) compared to
our study (Rajab et al., 2012). The difference in the burden of GDM among most
gulf countries despite similar ethnicity and life style factors could be due to different
measurement methods and diagnostic criteria for GDM.

Consistent with the vast body of literature that the burden of GDM is higher in
Middle Eastern countries than other population, our incidence rate of GDM was
higher than European and American countries. For example, studies have reported
that the prevalence of GDM in Australia was 9.5%, the USA 4.8%, France 12.5%
and other European Countries was 2 - 6% (Moses et al., 2011; Ferrara et al., 2007;
Schneider et al., 2011).

4.4 Association between Gestational Diabetes and Vitamin D

Our study did not find a significant association between vitamin D deficiency
in early pregnancy and GDM. The lack of association between vitamin D status and
GDM could be due to various reasons. The vitamin D deficiency alone might be
neither sufficient nor a necessary factor to cause GDM. Moreover, we measured
vitamin D once in early pregnancy, which may not depict its true status during
pregnancy given that studies have shown progressive decline in its levels with
advancing pregnancy. Another possible reason for the lack of association could be
due to the diagnostic criteria of GDM.

To the best of our knowledge, it was the first cohort study that examined the
association between vitamin D and GDM in the UAE. Therefore, comparable data
are not available in the country. Also, studies assessing the association between
vitamin D and GDM are scarce in the Gulf and other Middle East countries. As such,
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only one cohort study was conducted in Qatar (Bener et al., 2013), whereas other
studies that assessed the relationship between these conditions were case-control and
/ or cross-sectional in nature and found mixed results. To elaborate, a small crosssectional study from Egypt like our study found similar average vitamin D levels in
GDM versus non-GDM women (El Lithy et al., 2014). Another cross-sectional study
conducted in Turkey also reported similar prevalence of vitamin D in women with
GDM versus those without GDM (44% vs 44.7%, p = 0.9) (Ates et al., 2017).
Similarly, a case-control study from Turkey did not find any correlation of serum
vitamin D with serum fasting glucose (p = 0.9), insulin levels (p = 0.2) or HbA1c
levels (p = 0.1) (Parildar et al., 2013). Contrary to our findings, two cross-sectional
studies from Iran found an inverse association between HbA1c, insulin resistance,
GDM and vitamin D (Jafarzadeh et al., 2015; Maghbooli et al., 2008). Also, a crosssectional study conducted in Turkey showed a significant association between severe
vitamin D deficiency and GDM (Zuhur et al., 2013). Similarly, a matched casecontrol study from Iran showed 2.66 higher odds of vitamin D deficiency in women
with GDM as compared to those without GDM (Soheilykhah et al., 2010). Given
these conflicting results, this study served as a valuable addition to literature
concerning the association between vitamin D and GDM in the Middle East region.

Like the Middle East region, observational studies from other countries reported
inconsistent results about the relationship between vitamin D and GDM. Like our
study, no association was found between vitamin D deficiency and GDM among
Indian women (Farrant et al., 2009). Likewise, two case-control studies from the UK
showed that vitamin D levels in early pregnancy were not significantly different by
GDM status (Makgoba et al., 2011; Savvidou et al., 2011). Furthermore, a nested
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case control study carried out on pregnant women in the USA reported a lack of
association between first trimester vitamin D levels and GDM (Baker et al., 2012).
Also, a Korean cohort study found that levels of vitamin D were similar throughout
pregnancy in both GDM and non-GDM groups (Park et al., 2014). In contrast to our
study, a prospective study from Australia revealed significant and inverse association
between serum vitamin D concentration (29 weeks of gestation) and fasting glucose
(Clifton-Bligh et al., 2008). Two nested case control studies from the USA and one
study from Canada demonstrated more than two-folds higher risk of GDM with
lower levels of vitamin D in early pregnancy (Arnold et al., 2015; Cuilin Zhang et
al., 2008; Parlea et al., 2012). Also, a cross-sectional study in Turkey showed that
only women with severe vitamin D deficiency were more likely to have GDM
(Zuhur et al., 2013). Similarly, two large nested case control studies carried out in
China and India claimed vitamin D deficiency in early pregnancy as an independent
risk factor of GDM (Jain et al., 2015). The conflicting results documented by earlier
studies might be due to methodological issues such as sample size, study design,
gestational age at which GDM and vitamin D were measured and methods adopted to
measure vitamin D. Other reasons include criteria for diagnosing GDM and vitamin
D and ethnic and genetic characteristics of study populations.

Contrary to conflicting results of observational studies, systematic reviews and
meta-analysis have unanimously shown that vitamin D deficiency is a significant risk
factors of GDM. Wei and colleagues in their meta-analysis of 12 studies showed 1.38
times increase in odds of GDM (95% CI: 1.12-1.70) due to vitamin D insufficiency
in early pregnancy (S.-Q. Wei et al., 2013). Similarly, another meta-analysis by Lu
and colleagues comprising 20 observational studies reported 1.45 times greater risk
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of GDM (95% CI: 1.15 - 1.81, p < 0.001) with vitamin D insufficiency (Lu &
Zhang, 2016). Similarly, Zhang and colleagues concluded that vitamin D deficiency
increased the odds of GDM by 1.53 (95% CI: 1.33-1.75), while odds of GDM were
1.61 (1.19 - 2.17; p = 0.002) times in vitamin D deficient versus non-deficient
women according to Poel et al (Zhang et al., 2015; Poel et al., 2012). A metaanalysis that included 31 studies confirmed that vitamin D insufficiency (OR 1.49,
95% CI: 1.18 - 1.88) and lower vitamin D levels (Pooled average difference: -7.36
nmol/L, 95% CI: -10.16 to -4.56 nmol/L) were significantly associated with an
increased risk of GDM (Aghajafari et al., 2013). Despite the consistent findings, the
quality of this meta- analysis is compromised by many factors such as the
observational study designs, diverse study populations, different laboratory methods
and timings of measuring vitamin D and GDM and heterogeneity in diagnostic
criteria and definition of GDM and vitamin D.

4.5 Association between Gestational Diabetes and Diet

To our knowledge, this was the first study that assessed the role of diet in the
development of GDM among Emirati women. Our data showed that daily
consumption of dates and red meat in early pregnancy significantly increased the risk
of GDM while fiber, fruits, vegetables and beverages were not associated with
increased risk of GDM. Our results suggest that diet plays an important role in the
development of GDM and educating pregnant women about maintaining a healthy
and well-balanced diet can be an effective intervention in preventing the incidence of
GDM.
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Plausible biological mechanisms for the association between meat consumption
and GDM are not very clear. The red meat contains cholesterol and saturated fats,
which negatively affect insulin sensitivity and ß-cell function of pancreas and
thereby may increase the risk of GDM. According to another assumption, AGEs and
iron present in the meat increase the risk of type 2 diabetes and GDM (Bao et al.,
2014; Zhang & Ning, 2011).

Epidemiological evidence regarding relationship between fat and meat
consumption and GDM is recent and largely favors our study findings. For instance,
Bao and others found that intake of high animal protein in particular red meat
increased the risk of GDM by two-folds (Bao et al., 2013). According to another
cohort study, high intake of saturated fats during pregnancy significantly increased
the risk of GDM (Saldana et al., 2004). Also, the Nurses‘ Health Study II revealed
that intake of Western diet that primarily contained red and processed meat increased
the risk of GDM (C. Zhang et al., 2006). Another large prospective study identified
that only high intake of animal fat and cholesterol was associated with increased risk
of GDM (Bowers et al., 2012). Furthermore, a study from China demonstrated that
consumption of unsaturated fats significantly reduced the risk of GDM (Wang et al.,
2000). Another study showed that consumption of red (OR:2.37, 95% CI: 1.49, 1.493.78, p < 0.001) and processed meat (OR:2.01, 95% CI: 1.26 - 3.21, p = 0.003)
before pregnancy significantly increased the risk of GDM in a Mediterranean cohort
(Marí-Sanchis et al., 2017). In line with cohort studies, a case-control study found
that the consumption of saturated fats doubled the odds of GDM, while of
unsaturated fats decreased the odds of GDM by 15% (Bo et al., 2001). On the other
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hand, a cohort study carried out by Radesky reported no association between red
meat consumption and risk of GDM (Radesky et al., 2008).

Dates are among the most consumed fruits in the UAE and have high glycemic
index and medium glycemic load (Harvard Medical School, 2015). Although,
relationship of GDM has not been done directly with dates; a wealth of research
comprising mainly clinical trials has explored the role of low and high glycemic diet
in the development of GDM. A large cohort study documented 2.15 increased risk of
GDM among those women who ate high glycemic and low fiber diet (Zhang et al.,
2006). A small clinical trial demonstrated a significant control in postprandial
glucose due to low glycemic index diet in women (Grant et al., 2011). Another
clinical trial showed that number needed to use insulin was reduced by half in those
who received low glycemic index diet in women with GDM (Moses et al., 2009). In
contrast, Redesky and others reported no association of high carbohydrate diet and
any dietary pattern with risk of GDM respectively (Radesky et al., 2008).

In addition to observational studies and clinical trials, current systematic
reviews and meta-analysis have backed our results and concluded that low glycemic
diet significantly improved glucose and insulin control in women with GDM and
healthy diet reduced the incidence of GDM. However, the most of these reviews
have emphasized that existing observational studies and clinical trials that were
included in analysis had small sample size and lacked quality to draw any
conclusions and recommendations about modifying current dietary recommendations
in pregnancy (Wei et al., 2016; Viana et al., 2014; Louie et al., 2013; Louie et al.,
2010). Therefore, more research in this area is needed to better understand the
contribution of dietary factors in the development of GDM.
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4.6 Association between Gestational Diabetes and Physical Activity

Adequate exercise has various beneficial effects on the course of pregnancy,
labor and health of both mother and fetus (Dempsey et al., 2004). However, research
has shown that amount of physical activity is decreased significantly particularly in
early pregnancy due to nausea and fatigue and perceived risk to maternal and fetal
health (Perichart-Perera et al., 2009). This issue might be one of reasons for low
physical activity levels of pregnant women in our study. Other reasons might be
associated with life style practices and extreme weather conditions. However, we
could not find any study on barriers of physical activity among Emirati pregnant
women, therefore comparisons cannot be made.

In this study, moderate and high physical activity in early pregnancy did not
lower the risk of GDM among Emirati women. We did not find any study related to
this research area in the UAE and neighboring countries. However, our results are
against the bulk of studies conducted in different countries. For instance, an
observational study mentioned that the risk of GDM was decreased by 20 - 55% in
those women who are perform various types and intensities of recreational physical
activity during and before pregnancy (Redden et al., 2011). Moreover, according to a
prospective study, women who performed vigorous physical activity 12 months
before their pregnancy had a 56% lower risk of developing GDM (Dempsey et al.,
2004). Another study showed that women who performed recreational physical
activity during first twenty weeks of pregnancy were at 44% lower risk of developing
GDM than inactive women (Oken et al., 2006). Also, two systematic reviews found
that likelihood of GDM was reduced by 25 and 18% respectively in physical activity
intervention groups versus control groups (Russo et al., 2015; Da Silva et al., 2016).
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In contrast, some evidence has reported lack of association between physical activity
and the risk of GDM, which is in line with our results. For instance, a review of
thirteen randomized control trials revealed that risk of GDM was insignificant
between intervention (diet and exercise) and control group (Bain et al., 2015). Ploeg
did not find any association between sedentary time, physical activity and
development of GDM in proceeding three years (Ploeg et al., 2011).

The lack of association between low physical activity and GDM in our study
could be due to the utilization of a self-reported physical activity measurement tool,
which might have diluted the magnitude of association between these variables. In
addition, physical activity during the first trimester of pregnancy might not be as
significant risk factor as physical activity before pregnancy or later trimester.
Therefore, we recommend using objective tools for measuring physical activity for
more reliable findings and exploring the possible role of time of physical activity in
the development of GDM.

4.7 Association between Gestational Diabetes and Body Mass Index

The present study found that increase in pre-pregnancy BMI by one unit
increased the likelihood of GDM by 7% after controlling for physical activity, diet,
vitamin D and age. The association between obesity and GDM is explained by
various mechanisms in the literature. Obesity brings various metabolic changes in
pregnancy including insulin resistance, which can lead to the development of GDM.
Obesity is also known to be associated with defects in insulin receptors. Moreover, in
obesity abundant adipocytes are released, which may produce excess inflammatory
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markers and eventually leads to the development of GDM (Kaaja & Rönnemaa,
2008).

Our findings are consistent with previous epidemiological data that have
consistently demonstrated obesity to be a strong predictor of GDM. According to
some studies, BMI above 30 kg/m2 increases 2 - 4 fold risk of GDM
(Mohammadzadeh et al., 2015; Lin et al., 2016; Radesky et al., 2008). Systematic
reviews and meta-analysis have also confirmed this association and have
demonstrated an increase in strength of association of GDM with severity of obesity.
According to Chu and others the risk of GDM was two, four and eight times higher
among overweight, obese and very obese women respectively as compared to normal
weight women (Chu et al., 2007). Another meta-analysis reported that overweight,
moderately obese and morbidly obese women were two, three and four times likely
to have GDM respectively (Torloni et al., 2009).

Although, an extensive body of evidence has confirmed association between
increasing BMI and GDM, the magnitude of association varies significantly across
studies. The possible reasons could include genetic predisposition to GDM in obese
different populations, differences in measurement and diagnostic guidelines of GDM
and obesity and presence of interaction and confounding factors which were not
handled in individual studies. Regardless of these limitations, it is obvious from our
study and previous data that obesity is a strong risk factor of GDM in Emirati women
and elsewhere and should be tackled at global scale.
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4.8 Association between Gestational Diabetes and Family History of Diabetes

Research has extensively shown that family history of diabetes is an established
risk factor of GDM. For instance, Salomon et al. reported that family history of
diabetes increased the risk of GDM by 68% (Solomon et al., 1997). Lin and
colleagues observed seven-folds higher risk of GDM in women with positive family
history than those without family history of diabetes (Lin et al., 2016). Cianni found
two times higher prevalence of GDM in pregnant women with positive family
history of diabetes (14.5 vs. 7.3%) compared with women with negative family
history of GDM (Di Cianni et al., 2003). Likewise, Yang and Erem found that twofold and 4.5 fold higher risk of GDM respectively in women with positive family
history of diabetes than those with negative family history of diabetes (Yang et al.,
2009; Erem et al., 2015).

Coinciding with global estimates, studies from the Middle East and gulf
countries have considered the family history of diabetes as a strong risk factor of
GDM. A cohort study from Iran and cross-sectional studies from Turkey and Yemen
found that the incidence and prevalence of GDM was significantly higher in women
with positive family history of diabetes (Shirazian et al., 2009; Duman et al., 2015;
Ali et al., 2016). To add further, a systematic review concluded that women with
positive family history of diabetes were 3.46 times more likely to have GDM than
those without any history of type 2 diabetes (Moosazadeh et al., 2017).

Our results are in accordance with earlier studies from gulf countries and
elsewhere as we found 93% higher odds of GDM in women having positive family
history of diabetes versus those with negative family history of diabetes. The
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consistency of findings confirms that family history of diabetes is a crucial risk factor
of GDM. Therefore, pregnant women must be screened for the presence of family
history of diabetes along with other major risk factors while screening for GDM.

4.9 Strengths of the Study

This was the first cohort study in the UAE that estimated the incidence of GDM
in the UAE and prospectively assessed the association of vitamin D deficiency and
other factors with the development of GDM. In addition, the measurement of vitamin
D, physical activity and diet in early pregnancy enabled the researcher to establish
the temporal relationship between maternal vitamin D deficiency and subsequent risk
of GDM in second and third trimester of pregnancy.

Although, more than 80% of the participants had vitamin D deficiency or
insufficiency, the sample size of 563 pregnant women was adequate to compare
exposed and non-exposed groups. Also, this sample size achieved the power of 80%
to detect the true difference in risk of GDM in vitamin D deficient women versus
non-deficient women.

Cohort studies are subjected to high rate of loss to follow-up. The high follow-up
rate reduced attrition bias (the attrition rate was 11.2 %) and did not undermine the
power of study.

It was a well-designed study that used strict inclusion criteria. The strict criteria
allowed the researcher to minimize selection bias and excluded potential
confounding factors of GDM such as multi-parity, chronic diseases and previous
history of GDM.
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This study used internationally validated tools and diagnostic criteria to measure
exposures and the outcome. The two-step method was employed to diagnose GDM
and IOM criteria to determine vitamin D deficiency. Secondary exposures such as
physical activity and diet intake were measured using GPAQ and FFQ. This
approach allowed the researcher to accurately measure and compares our results with
most of other studies. Moreover, this study measured all known confounding factors
and included these in statistical analysis to determine the association between
vitamin D and GDM.

Although, the study was conducted in one Emirate of the UAE; its findings can
be generalized to all Emirati women because of similar living and socio-cultural
characteristics of women across all Emirates.

4.10 Limitations of the Study

This study prospectively assessed the temporal association of vitamin D
deficiency, physical activity (during the last week) and diet (during the last year)
with the subsequent development of GDM. However, observational nature of this
study could not establish causal relationship between vitamin D deficiency and GDM
and underscores the need of well-designed experimental studies.

Although, it was a well-designed study that measured and adjusted for all known
confounders of vitamin D and GDM, there is every possibility that some unknown
confounding factors were not measured by the researcher. Therefore, residual
confounding may exist in the relationship between vitamin D and GDM. Considering
this limitation, randomized control trials would be an ideal choice for studying the
relationship between these conditions.
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The information regarding physical activity was collected by using the GPAQ,
which is a widely used and internationally validated tool. However, it collects selfreported data on physical activity in the past one week. This limitation might have
led to over- or under-reporting of physical activity and recall bias. These two
limitations may partly explain the lack of significant association between physical
activity and the development of GDM. In the view of this limitation, objective
methods of measuring physical activity are suggested to accurately assess the
relationship between physical activity and GDM.

Studies have consistently shown that vitamin D levels vary throughout the
pregnancy. However, in this study, vitamin D levels were measured only once in the
first trimester of pregnancy. Therefore, a single measurement of vitamin D does not
reflect the status of vitamin D in pregnancy and might have affected its degree of
association with GDM.

Frequencies of food intake were used as a proxy for a quantitative indicator in
the present study, the misclassification of food intake might have occurred. Such bias
could have resulted in insignificant results with many of food groups. Second, we
assessed food intake ‗in the past Year‘. The information during this period might not
be representative of dietary habits throughout early pregnancy as it represents the
dietary intake before pregnancy. However, previous studies have suggested that
overall dietary patterns remain stable during pregnancy. Therefore, objective and
accurate tools are needed to determine the exact association between dietary pattern
and GDM.
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4.11 Conclusion

This study found that vitamin D deficiency and low physical activity were not
significant risk factors of GDM, while daily consumption of dates and red meat,
positive family history of diabetes and increasing BMI were identified as significant
risk factors of GDM among Emirati women. In addition, the incidence rate of GDM
and prevalence rate of vitamin D deficiency was high in Emirati population.

4.12 Recommendation

Prevention of GDM by lifestyle changes including diet and physical activity
may ensure a healthier future for both child and mother. These findings suggest that
dietary modification and weight management interventions are required in pregnancy
to reduce the risk of GDM and prevent its short and long-term maternal and neonatal
complications. All women should receive diet therapy and nutritional advices from
an appropriately skilled dietitian, to promote facilitate weight control and improve
insulin sensitivity.

As the prevalence of vitamin D deficiency and insufficiency was high, we
recommend that the main food items in like breakfast cereals, rice, flour, cooking oil,
dairy products, fruit juice, eggs and bread should be fortified with enough amount of
vitamin D and the women should be advised to be exposed to the sun at least 20 – 30
minutes for 3 - 4 days weekly.

More experimental studies are required to measure physical activity and
dietary intake and unified methods and diagnostic criteria for GDM and vitamin D
are recommended to accurately investigate the risk factors of GDM.
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4.13 Output of the study

The abstract of the study has been presented in two conferences
1. Poster presentation (22 - 23 March, 2017) in ―Vitamin D deficiency, diet,
physical activity and development of Gestational Diabetes in Emirati women
in Ras Al Khaimah - UAE‖ at 16th Global Diabetes Conference and
Medicare Expo, Holiday Inn, Rome, Italy
2. Poster presentation (9 - 10 March, 2017) in ―Diet, Physical activity in early
pregnancy and development of GDM in Emirati women in Ras Al Khaimah UAE‖ at 6th International Conference Vitamin D Deficiency, Nutrition and
Human Health (MENA conference), Intercontinental Hotels & Resorts, Abu
Dhabi, U.A.E.
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Appendix 1: Socio-demographic Characteristics Questionnaire
Socio-demographic Characteristics Questionnaire

Gestational diabetes mellitus and vitamin D deficiency in RAK (2014-2016)
United Arab Emirates University - Medicine and Health Sciences - Public Health
Department
Code

Response

1

File/ Card number:

2

Participant‘s name:

3

Contact number 1:

4
5
6
7
8
9

10

Contact number 2:
Health care center‘s name:
Date of your last menstrual
period:
Date of birth/ age:
Date of drawing first blood
sample:
Date of first visit:
In total, how many years have
you spent at school or in fulltime study (excluding preschool)?
What is the highest level of
education you have
completed?

11

What is your marital status?

12

Which of the following best
describes your main work
status over the past 12

Years
_____

No formal schooling 1
Less than primary school 2
Primary school completed 3
Secondary school completed 4
High school completed 5
College/University completed 6
Post graduate degree 7
Refused 8
Currently married 1
Separated2
Divorced 3
Widowed 4
Refused 5
Government employee 1
Non-government employee 2
Student 3
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months?

13

14

15

Homemaker 4
Retired 5
Unemployed (able to work) 6
Unemployed (unable to work)7
Self-employed 8
Refused 9
Number of people
_____

How many people older than
18 years, including
yourself, live in your
household?
Taking the past year, can you per month _______________
tell me what the
OR per year ______________
average earnings of the
Refused 0
household have been?
(RECORD ONLY ONE, NOT
ALL2)
Medical History
Do you have a family history
of Diabetes?

Yes 1
No 2
I Don‘t know 3
16
Do you have diabetes
Yes 1
mellitus?
No 2
I Don‘t know 3
17
Have you had gestational
Yes 1
diabetes before?
No 2
I Don‘t know 3
18
Do you have Hepatitis or liver Yes 1
diseases?
No 2
I Don‘t know 3
19
Do you have Aids?
Yes 1
No 2
I Don‘t know 3
20
Do you have kidney diseases? Yes 1
No 2
I Don‘t know 3
21
Are you vitamin D deficient?
Yes 1
No 2
I Don‘t know 3
This part should be filled by the principal investigator or the research assistant
22
Height
in Centimeters (cm):
23
Weight in pregnancy:
in Kilograms (kg):
24
Body Mass Index (BMI) in
pregnancy :
25
Weight before pregnancy:
in Kilograms (kg):
26
Body mass index (BMI) before ____________
pregnancy:
27
Blood Pressure:
mm Hg
28
Place of doing blood analysis:

119
29
30
31

32

Fasting blood glucose at
baseline
Vitamin D level
OGTT (24-28) weeks - fasting
OGTT (24-28) weeks - 2hr (75
gm)
Do you have diabetes after
(24-28) weeks of pregnancy or
after the delivery:

mmol/l:
ng/ml:
mmol/l:
mmol/l:
Yes (
No (

Name of Health Care Center: __________________
Interviewer name: ________________
Signature: ______________
Date: ______________

)
)
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Appendix 2: Global Physical Activity Questionnaire
Global Physical Activity Questionnaire
Gestational diabetes mellitus and vitamin D deficiency in RAK (2014-2016)
United Arab Emirates University - Medicine and Health Sciences - Public Health Department
CORE: Physical Activity
Next I am going to ask you about the time you spend doing different types of physical activity in a
typical week. Please answer these questions even if you do not consider yourself to be a physically
active person.
Think first about the time you spend doing work. Think of work as the things that you have to do such
as paid or unpaid work, study/training, household chores, harvesting food/crops, fishing or hunting for
food, seeking employment. [Insert other examples if needed]. In answering the following questions
'vigorous-intensity activities' are activities that require hard physical effort and cause large increases in
breathing or heart rate, 'moderate-intensity activities' are activities that require moderate physical effort
and cause small increases in breathing or heart rate.
Question
Response
Code
Working and job related physical activity
Does your work involve vigorous1
Yes
intensity activity that causes large
increases in breathing or heart rate like
1
P1
2
If
[carrying or liftingheavy loads, digging
No
No,
go
or construction work, running] for at
to P 4
least 10 minutes?
2

3

4

In a typical week, on how many days do
you do vigorous-intensity activities as
continuously?
part of your work?
[INSERT EXAMPLES] (USE
SHOWCARD)
How much time do you spend doing
vigorous-intensity activities at work on a
typical day?

Does your work involve moderateintensity activity, which causes small
increases in breathing or heart rate such
as brisk walking [or carrying light loads]
for at least 10 minutes continuously?

5

In a typical week, on how many days do
you do moderate-intensity activities as
part of your work?

6

How much time do you spend doing
moderate-intensity activities at work on a
typical day?

P2

# of days

Hour

P3
(a-b)

Minute
Yes

1

No

2
If No,
go to
P7

P4

P5

# of days:

Hour

P6
(a-b)

Minute
Travel and transportation related physical activity
The next questions exclude the physical activities at work that you have already mentioned.
Now I would like to ask you about the usual way you travel to and from places. For example, to work,
for shopping, to market, to place of worship. [Insert other examples if needed]

7

Do you walk for at least 10 minutes
continuously to get to and from places?

Yes

1

No

2 If
No, go

P7

121
to P
10

8

In a typical week, on how many days do
you walk for at least 10 minutes
continuously to get to and from places?

9

How much time do you spend walking
for travel on a typical day?

P8

# of days:

Hour

P9
(a-b)

Minute

Question

Response

Code

Recreational and leisure time activities
The next questions exclude the work and transport activities that you have already mentioned.
Now I would like to ask you about sports, fitness and recreational activities (leisure)

10

Do you do any vigorous-intensity sports,
fitness or recreational (leisure) activities
that cause large increases in breathing or
heart rate like [running or football] for at
least 10 minutes continuously?
[INSERT EXAMPLES] (USE
SHOWCARD)

11

In a typical week, on how many days do
you do vigorous-intensity sports, fitness
or recreational (leisure) activities?

12

How much time do you spend doing
vigorous-intensity sports, fitness or
recreational activities on a typical day?

13

14

Do you do any moderate-intensity sports,
fitness or recreational (leisure) activities
that cause a small increase in breathing or
heart rate such as brisk walking, [cycling,
swimming, and volleyball] for at least 10
minutes continuously?
[INSERT EXAMPLES] (USE
SHOWCARD)
In a typical week, on how many days do
you do moderate-intensity sports, fitness
or recreational (leisure) activities?

Yes

1

No

2 If
No, go
to P
13

P10

# of days:

P11

Hour

P12
(a-b)

Minute

Yes

1
P13

No

# of days:

2
If
No, go
to P16

P14

How much time do you spend doing
moderate-intensity sports, fitness or
Hour
P15
15
recreational (leisure) activities on a
(a-b)
Minute
typical day?
Sedentary behavior (sitting)
The following question is about sitting or reclining at work, at home, getting to and from places, or with
friends including time spent sitting at a desk, sitting with friends, traveling in car, bus, train, reading, or
watching television, but do not include time spent sleeping.
How much time do you usually spend
P16
16
Hour Minute
sitting or reclining on a typical day?
(a-b)
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Appendix 3: Adult Semi-Quantitative Food Frequency Questionnaire
Adult Semi-Quantitative Food Frequency Questionnaire
During the past year, on average, how often have you consumed the following food?
(Please check the appropriate box)

Dairy products
1. Milk: Serving = 1 cup =200 ml
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

2. Yogurt: Serving = 1 cup =200 ml
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

Fruits
3. Fruits: Banana: Serving = 1 medium
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

4. Dates: Serving = 3 medium
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

5. Grapes: Serving = 10 peces
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

6. Mango: Serving = 1 medium
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

Vegetables
7. Fresh vegetables : Serving = 1 cup
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

8. Cooked Vegetables: Serving = ½ cup
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

9 . Green leafy vegetables (spinach, mint, lettuce): Serving = 1 cup
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

Meat
10. Fresh red meat (lamb or beef etc): serving = 90-120 g
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>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

11. Processed meat (lamb or beef or chiken etc): Serving = 90-120 g
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

12. Fresh white meat (chiken or poultary): Serving = 90-120 g
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

13. Fish: Serving is medium size fish ~200 g
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

Breads, cereals and starches
14. White rice: Serving = 1/2 cup (cooked) ~ 100 g
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

15. Bread: serving = 1 medium
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

16. Pasta and spaghetti: Serving = ½ cup (cooked) ~ 100 g
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

Drinks
17. Tea: Serving: 1 cup = 200 ml
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

18. Coffee or Nescafe: Serving: 1 cup = 200 ml
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

19. Fresh or caned juice: Serving = 1 cup ~ 200 ml
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

20. Coke, Pepsi or any kind of soft drink: Serving = 1 cup ~ 200 ml
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

Sweets
21. Sweets (baklava, konafa, cookies, chocolate, mahlabiyyeh.. etc): Serving: 100 g
(1/2 cup)
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□
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Seeds and nuts
22. Seeds and nuts (almond, cashew, peanut, pistachio, walnut etc): Serving = 10
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

Miscellaneous
23. Pizza: Serving: 1 medium slice
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

24. Boiled potato: Serving = 200 g (1 cup)
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

25. French fries: Serving = 100 g (½ cup)
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

26. What kind of oil usually used for cooking at home?

□

Corn

Sunflower

Canola

Olive

> 1 type

I do not know

□

□

□

□

□

27. What is the frequency of using oil in cooking at home? Serving = ½ cup
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

28. What kind of cooking fat usually used in cooking at home?

□

Butter

Ghee

Palm

□

□

> 1 type

□

I Do not know

I do not use

□

□

29. What is the frequency of using fat in cooking at home? Serving = ½ cup
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

30. How often do you eat meals at a fast food/non-fast food restaurant and at
work?
>6/day

□

4-5/day

2-3/day

1/day

5-6/wk

2-4/wk

1/wk

1-3/mo

˂ 1/ mo

□

□

□

□

□

□

□

□

Vitamins and Minerals
31. Do you regularly take vitamins or minerals during the past six months?
Yes

□

No

□

Do not know

□

32. If yes, how often you take vitamins or minerals?
< one year

□

1-3 years

□

4-6 years

□

>6 years

33. Do you regularly take vitamin D pills during the past six months?
Yes

□

No

□

34. If yes, how often you take vitamin D pills?

Do not know

□

□

125
< one year

□

1-3 years

□

4-6 years

□

>6 years

□
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Appendix 6: Informed Consent (Facts about the Study)
ح اىَرذذجٞجاٍؼح اإلٍاساخ اىؼشت
حٞح اىطة ٗاىؼيً٘ اىصذٞمي
قسٌ غة اىَجرَغ
Facts about the Study
Purpose:

حقائق عه الذساسة

We are doing this study in eight primary
health care centers (Ras Alkhaimah, AlDigdaga, Al-Dhait, Julfar, Al-rams, Almamoura, Al-Jazirah Al-Hamra, Shamal
and Al-Nakheel health care centers), in
RAK city in the UAE. To find out the risk
factors for Gestational Diabetes Mellitus
and the relationship between vitamin D
deficiency and developing this disease.
The results which will be obtained from
this study will help us find out the risk
factors of Gestational Diabetes Mellitus in
Emirati citizens in RAK city in UAE.
Researchers:
A multidisciplinary team consisting of
researchers from the Department of
Community Medicine, (UAEU).
The principal investigator Mrs. Sharifa Ali
(PhD student), and the advisor Dr.
Abdureehim Oulhaj.
Selection criteria:
514 of Emirati pregnant women aged (1845) in the eight primary health care centers
in RAK city in the UAE will be asked to
participate in this study.
When? Scheduled to begin the process of
selection and data collection in May 2014
and will continue to the beginning of
February 2016.
Benefits to participants: You will help to
contribute valuable information about diet
and physical activity patterns among
pregnant women in the UAE. This
information will help researchers to
identify the risk factors that are related to
the development of gestational diabetes in
Emirati pregnant women. To manage and
reduces GDM and type 2 diabetes.

: الغشض
ٚرشددُ ػيٝ ٜذشَو ٕزٓ اىذساسح اىْساء اىذ٘اٍو اىي٘اذ
ادج اىذ٘اٍوٞح ػٞح األٗىٞح اىصذٝح ٍشامض ىيشػاّٞ شَاٜف
، ٍشمض اىَؼَ٘سج،َحٞ ٍشمض سأط اىخ،وٞ(ٍشمض اىْخ
،دٞ ٍشمض اىظ، ٍشمض اىذقذاقح،ٍشمض جيفاس ٍشمض شَو
 إٍاسج سأطٜ) فٜشج اىذَشاء اىصذٍٝٗشمضاىجض
ح اىَرذذج ٗرىل ىيرؼشفَٞح تذٗىح اإلٍاساخ اىؼشتٞاىخ
ٓخ ٕزٞ مَا ذر، اىذٗىحٜ اىذَو فٛأسثاب إّرشاس سنش
 اىذَو ّٗقصِٛ سنشٞ اىؼالقح تٚاىذساسح اىرؼشف ػي
س أشثرد تؼط اىذساساخ أُ ْٕاك ػالقحٞ د،ِ دٍٞراٞف
 اىذَو تاإلظافحِٛ د ٗاإلصاتح تسنشٍْٞراِٞ ّقص فٞت
اظح ٗاىغزاءٝاج ٍِ ٍَاسسح اىشٞ دساسح َّػ اىذٚإى
.  اإلٍاسجٜ اىذ٘اٍو اىَ٘اغْاخ فٙىذ
:الباحثون
قً٘ تٖزٓ اىذساسح تادصُ٘ ٍِ قسٌ اىصذح اىؼاٍحٝ
و دسجحْٞح اىَرذذج ىٞتجاٍؼح اإلٍاساخ اىؼشت
فحٝ اىطاىثح ششٜٕٗ  ىيثذسٜسٞاىذمر٘ساج ىيقائٌ اىشئ
ٚ اىَششف اىؼاً ػيٚ ػثذاىشدَِ تاإلظافح إىٜػي
.ٌ اىذاضٞػثذاىشد.اىثذس ٕٗ٘ د
:معاٌٍش االختٍاس
ح داٍو ذرشاٗحٞ) إٍشأج إٍاساذ514( ٍِ طيةٞس
حٞ اىَشامض اىصذٜ <; سْح ف-8? ِٞأػَاسٌٕ ٍا ت
حَٞح تذٗىح اإلٍاساخ اىؼشتٞ إٍاسج سأط اىخٜح فّٞاىصَا
. ٕزٓ اىذساسحٜاىَرذذج اىَشاسمح ف
اس ٗجَغٞح االخرٞمتى؟ ٍِ اىَقشس أُ ذثذأ ػَي
918= شٝ فثشاٚ ٗسرسرَش إى918;  ٍاسطٜاّاخ فٞاىث
:فوائذ للمشاسكٍه
ِٛ سنشٞ اىؼالقح تٚخ ٕزٓ اىذساسح اىرؼشف ػيٞذر
س أشثرد تؼط اىذساساخٞ د،ِ دٍٞراٞاىذَو ّٗقص ف
ِٛ د ٗاإلصاتح تسنشٍْٞراِٞ ّقص فٞأُ ْٕاك ػالقح ت
اج ٍِ ٍَاسسحٞ دساسح َّػ اىذٚاىذَو تاإلظافح إى
. اإلٍاسجٜ اىذ٘اٍو اىَ٘اغْاخ فٙاظح ٗاىغزاء ىذٝاىش
ذ ػ٘اٍوٝ ذذذِٜ فٞذساػذ ٕزٓ اىَؼيٍ٘اخ اىثادص
 اىذَو ػْذ اىَ٘اغْئخٛاىخط٘سج اىَشذثطح تسنش
 اىذَوٛو ٍِ داالخ سنشٞ اىرقيٜاخ ٗتاىراىٞٞاإلٍاساذ
س أشثرد اىذساساخٞ دٛ ٍِ اىسنشٛٗمزىل اىْ٘ع اىصا
ٚ اىذَو ٍَنِ أُ ذرذ٘ه إىٛ ٍِ سنش%=1-81 ُأ
 سْ٘اخ تؼذ81-<  خالهٛ ٍِ اىسنشّٜاىْ٘ع اىصا
. ُ اىَر٘اصٜ اىصذٜرثغ اىْظاً اىغزائٝ ٌاى٘الدج إرا ى

What participant will ask to do?

:مارا سٍفعل المشاسكون
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1) A study staff will do an interview with
you which will last 30-;< minutes.
2) We will ask you to complete three
questionnaires
(Food
Frequency
Questionnaire,
Physical
Activity
Questionnaire
and
demographic
information questionnaire).
3) Blood will be drawn from each
participant as a part of the routine care
in the health care center to measure
vitamin D level, fasting blood sugar in
the first visit and OGTT (oral glucose
tolerance test) will be done at (24-28)
gestation‘s weeks.
Questions?

قً٘ اىثادس تئجشاء ٍقاتيح ٍغ مو داٍو ذسرغشقٞ س.8 .8
رٌ ٍِ خالىٖا اسرنَاه شالز اسرَاساخٝ قحٞ<; دق-:1
ح ٗأَّاغٝ اىرغز،حَٞ٘غشافٝذرْاٗه اىَؼيٍ٘اخ اىذ
.ٍَّٜاسسح اىْشاغ اىثذ
.)ً ٗظغػ اىذ، ح (اى٘صُ ٗاىط٘هٝ٘ٞاساخ اىذٞ اىق.9 .9
 اىثذسْٜح ٍِ اىذً ٍِ مو ٍشاسمح فٞرٌ سذة ػٞس.3 .:
 اىَشمضٜ ٗاىؼالض اىَقذً فْٜمجضء ٍِ اىؼَو اىشٗذ
ٙ٘اط ٍسرٞ ٍو ٍِ اىذً ىق:  ٍغ اإلدرفاظ بٜاىصذ
و ادرَاه اىسنشٞرٌ ػَو ذذيٞ مَا س.َا تؼذٞ د فٍْٜراٞف
رٌ إػطاء اىذاٍوٞس سٞ) د9?-9;(  األسث٘عٜف
وٞششاب اىجي٘م٘ص <> جٌ ٍِٗ تؼذٕا إجشاء ذذي
. ىيَشمضِْٜٞ مجضء ٍِ اىؼَو اىشٗذٞاىسنش تؼذ ساػر
.4
:لالستفساسات
ٜفح ػيٝ ششA  اىثادصحٚ االذصاه ػيٌٚشج
َِػثذاىشد
1<1=;>>9;>Aٌٕاذف سق
Aّٜٗذ اىنرشٝتش

Please call : Sharifa Ali,
sharifa_ali_hashem@hotmail.com
Phone: 00971506477247
Email:
sharifa_ali_hashem@hotmail.com
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Appendix 7: Consent to Participate in a Research Study
Consent to Participate In a Research Study
TITLE OF STUDY: The relationship between vitamin D deficiency, diet, physical
activity and the development of Gestational Diabetes Mellitus in Ras Al Khaima in
the UAE.
UAEU Principal Investigator: Sharifa Ali Hashem Abdulrahman Albelooshi
Phone number: 00971504475985
Department: Community Medicine
Co-Investigator: Dr. Abderrahim Oulhaj
Department: Community Medicine
Phone number: 00971506477247
Study Contact phone number: 00971506477247
____________________________________________________________________
________
We are asking you to participate in an epidemiologic study that is a cohort study
from the United Arab Emirates University (UAEU).
You will be one of >8; of pregnant Emirati women who are counseling the primary
health care centers (Al Nakheel, Al Mamoura, Al Dhait, Aldigdaga, Alrams, Julfar,
Shamal and RAK Health care centers) in RAK city in the UAE. We describe details
of this study below. We want you to understand this information so that you can
decide whether or not you want to be in this study. Please ask questions if there is
anything that you do not understand. We will give you a copy of this form to keep
after signing.
What is the purpose of the study?
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We are doing this study in RAK city in the UAE to find out the relationship vitamin
D deficiency, diet, and physical activity and development of Gestational Diabetes.
The results which we will obtain from this study will help us to find out the risk
factors for Gestational Diabetes Mellitus in Emirati citizens in RAK city in UAE,
which could provide national guidelines to control the disease.
How long will you be in this study?
There will be one meeting which will last approximately 30-45 minutes.
What will you are asked to do during the study?
4) A study staff will do an interview with you which will last 30-45 minutes.
5) We will ask you to complete three questionnaires (Food Frequency
Questionnaire, Physical Activity Questionnaire and demographic information
questionnaire).
6) Blood will be drawn from each participant as a normal routine care in the health
care center to measure Fasting Blood sugar in the first visit and OGTT (75 g 2hr
postprandial) will be done at 24-28 gestation‘s weeks, and 3ml (about a teaspoon)
blood will be stored for vitamin D analysis .
7) You will be called after delivery by the principal investigator to conform the
development of gestational diabetes, if it has not been mentioned in your medical
record.

What are the possible risks and discomforts of being in the study?
This study poses no risk to you. However, this study might involve the following
discomforts to you.
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The in-person interviews include some personal questions about your behaviors (diet
and physical activity) and demographic information which may make you
uncomfortable.
Weight, height and blood pressure will be measured.
Blood will be drawn as a part of the routine care in the lab of the health care center or
Saqer hospital or Obaidallah hospital to measure Fasting Blood Sugar in the first
visit, and 3ml of the blood will be stored for vitamin D analysis. OGTT will be done
as a part of the routine care on (24-28) weeks of gestation.
What are the benefits of me being in the study?
You will help contribute valuable information about diet and physical activity
patterns for the pregnant women in RAK city in the UAE. This information will help
researchers identify risk factors that are related to developing gestational diabetes in
Emirati women in UAE and to explore the relationship between gestational diabetes
and vitamin D deficiency, future generations are likely to benefit as this results could
lower the prevalence of type 2 diabetes which is very common in UAE.
Are there any costs?
It will not cost you any money to be in this study.
Protection of privacy:
Your will be assigned a study number. All information you give will be stored only
with your study number, not with your name. Personal information that can identify
you and link you to your study number will be kept separate, and all information you
provide in this study will be kept completely confidential. These will be stored on
password protected computer files and only study staff will have access to that
information. We will make every effort to protect the identity of all participants in
this study.
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Right to refuse or to drop out of the study:
Your being in this study is your choice and your participation is voluntary. You can
decide not to be in this study at any time. You may refuse to answer questions and
still be part of this study. You may also choose to be in some parts of the study and
not in others. If you wish to drop out of the study or if you have any questions, please
call the study staff at 00971506477247 or email sharifa_ali_hashem@hotmail.com.
Offer to answer questions:
Today you can ask all questions you may have about this study. If you have more
questions

you

can

call

us

at

00971506477247

or

send

email

to

sharifa_ali_hashem@hotmail.com
Institutional Review Board approval:
The Ethics Committee in RAK Medical District and the Institutional Review Board
(IRB) in UAE both reviewed this study. These groups make sure that researchers
take care of study subjects.
If you have questions about your rights as a subject, you can call Institutional Review
Board (IRB) in UAEU at: +97137137463
And the Ethics Committee in RAK Medical District:
Dr. Abdullah Alabaasi – Saqer Hospital at: 0097172223666
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Participant’s Agreement:
I, the undersigned, have had the nature and purpose of the above named study
explained to me. I freely give my consent to be in this study. I understand that
participation is voluntary and that I may withdraw from the study at any stage. I
understand that not participating or withdrawing from the study will not have any
adverse effect on my employment or medical care. I have been given a subject
information sheet and the contact details of the Principal Investigators should I have
any questions at a later stage. I understand that any information I give will be treated
in the strictest confidence and will not be given to anyone outside the investigating
team without my express permission. After signing, I understand I will get a copy of
this consent form.
_________________________________________

_______________

Signature of Research Subject

Date

_________________________________________
Printed Name of Research Subject
_________________________________________

_______________

Signature of Person Obtaining Consent

Date

_________________________________________
Printed Name of Person Obtaining Consent
_________________________________________

_______________

Signature of Field Investigator

Date

_________________________________________
Printed Name of Field Investigator

Digitally signed by Shrieen
DN: cn=Shrieen, o=United
Arab Emirates University,
ou=UAEU Library Digitizatio,
email=shrieen@uaeu.ac.ae,
c=AE
Date: 2020.10.20 11:03:40
+04'00'

